WO2016102398A1 - Aqueous composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound, a polymer and a glycol - Google Patents

Aqueous composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound, a polymer and a glycol Download PDF

Info

Publication number
WO2016102398A1
WO2016102398A1 PCT/EP2015/080645 EP2015080645W WO2016102398A1 WO 2016102398 A1 WO2016102398 A1 WO 2016102398A1 EP 2015080645 W EP2015080645 W EP 2015080645W WO 2016102398 A1 WO2016102398 A1 WO 2016102398A1
Authority
WO
WIPO (PCT)
Prior art keywords
benzene
diol
tetrahydro
pyran
glycol
Prior art date
Application number
PCT/EP2015/080645
Other languages
French (fr)
Inventor
Marie-Lise CHIRON
Véronique Chevalier
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'oreal filed Critical L'oreal
Publication of WO2016102398A1 publication Critical patent/WO2016102398A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8176Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers

Definitions

  • An aqueous composition comprising a 4- (heterocycloalkyl) -benzene-1,3-diol compound, a polymer and a glycol
  • the subject of the present invention is a composition, preferably a cosmetic composition, comprising a 4- (heterocycloalkyl) -benzene-1,3-diol compound, a polymer and at least one glycol.
  • the 4- (heterocycloalkyl) -benzene-1,3-diol derivatives are compounds used for the treatment of cutaneous signs of aging and more particularly as a depigmenting agent for keratin materials.
  • these compounds be formulated in a solubilized form, and in particular at a high content, such as greater than or equal to 0.20% by weight, in order to make the most of their activity and it is also preferable that their solubilization is maintained over time to avoid any recrystallization phenomenon during the storage of compositions comprising such compounds.
  • solubilized forms lead to a better bioavailability in the skin than crystallized forms whose crystal size is poorly controlled.
  • bioavailability refers to the molecular penetration of the active agent into the living layers of the skin and in particular of the epidermis. It will be sought that the penetrated concentration is as high as possible, so as to increase the rate of asset reaching the living layers of the skin.
  • “solubilized form” is meant a dispersion of the derivatives according to the invention in a liquid, in the free molecular state, in particular in uncomplexed form. No crystallization of 4- (heterocycloalkyl) -benzene-1,3-diol derivatives is visible to the naked eye or in cross-polarized light microscopy.
  • compositions containing a high level of glycols provide a tacky and greasy feel of the skin. It is therefore sought to increase the solubility of these active ingredients but using limited quantities of solvents which reduce the cosmetic properties of the compositions.
  • the object of the present invention is precisely to propose a novel galenic formulation of the 4- (heterocycloalkyl) -benzene-1,3-diol compounds making it possible to overcome of the abovementioned disadvantages, and therefore to incorporate these compounds in a solubilized form and durable over time, these compounds being in particular present at a high content (such as a content greater than or equal to 0.20% by weight relative to the weight total of the composition).
  • This new galenic formulation of the compounds 4- (heterocycloalkyl) -benzene-1,3-diol makes it possible in particular to improve the efficacy of the active ingredient for the treatment of keratin materials such as the skin.
  • the compositions according to the invention make it possible to use lower amounts of glycols.
  • the inventors have in fact unexpectedly discovered that the combination of at least one 4- (heterocycloalkyl) -benzene-1,3-diol compound with at least one glycol and at least one nonionic or anionic polymer makes it possible to solubilize this compound while avoiding recrystallization, especially after storage for at least 1 week, or even 1 month, 2 months or more at room temperature (25 ° C) and / or at 4 ° C and / or 45 ° C .
  • the subject of the invention is a composition, in particular a cosmetic composition, comprising;
  • the present invention also relates to a process for preparing such a composition comprising the following steps:
  • step 1) of said process is the preparation of a solution A by mixing at least one polymer according to the invention and water by simply contacting with stirring (for example magnetic stirring) at room temperature. ambient temperature (20-25 ° C).
  • step 2) of said process is the preparation of a solution B by the mixture of at least one 4- (heterocycloalkyl) -benzene-1,3-diol compound in at least one glycol by heating, in particular by heating at a temperature of 40-60 ° C, preferably at about 50 ° C, for about 10 minutes with stirring (eg magnetic).
  • step 3) of said process is the mixture of solutions A and B by pouring solution A on solution B at room temperature.
  • the present invention relates to a process for preparing such a composition comprising the following steps:
  • Steps 1 and 2 of said method can be implemented in any order.
  • R1, R2, R3, R4, which may be identical or different, represent:
  • R1 and R2 are interconnected and form a carbon ring with 5 or 6 carbon atoms with the carbon atom to which they are bonded and R3 and R4, identical or different, represent: - a hydrogen
  • R1 and R4 are connected together and form a chain - (CH2) 2 - or - (CH2) 3 - and R2 and R3, which may be identical or different, represent:
  • a C1-C4 alkyl radical X represents an oxygen atom, or a sulfur atom.
  • Y represents a hydrogen, a chlorine atom or a fluorine atom.
  • salts of the compounds of general formula (I) there may be mentioned preferably salts with an organic base or with an inorganic base.
  • Suitable inorganic bases are, for example, potassium hydroxide, sodium hydroxide or calcium hydroxide.
  • Suitable organic bases are, for example, morpholine, piperazine, arginine, lysine.
  • the compounds of general formula (I) may also exist in the form of hydrates or solvates.
  • Suitable solvents for forming solvates are, for example, alcohols such as ethanol or iso-propanol.
  • the term C1-C4 alkyl denotes a saturated hydrocarbon chain, linear or branched, comprising from 1 to 4 carbon atoms.
  • C1-C4 alkyloxycarbonyl denotes a carboxy radical substituted with an alkyl radical containing from 1 to 4 carbon atoms.
  • C1-C4 alkoxy denotes an oxygen atom substituted by a linear or branched saturated hydrocarbon-based chain containing from 1 to 4 carbon atoms.
  • the isomers are the cis and trans forms relating to the substituents on the heterocycloalkyl at the 4-position of benzene-1,3-diol.
  • the compounds of general formula (I) that are particularly preferred are those for which:
  • R1 represents a hydrogen, a C1-C4 alkyl radical or a hydroxymethyl radical
  • R2 represents a hydrogen
  • R3 represents a hydrogen
  • R4 represents a hydrogen
  • X represents an oxygen atom
  • Y represents a hydrogen or a fluorine atom
  • the compound 4- (tetrahydro-pyran-4-yl) -benzene-1,3-diol is particularly preferred.
  • the compound of formula (I) may be present in the composition according to the invention, in a content ranging from 0.001% to 10% by weight, relative to the total weight of the composition, more particularly in a content ranging from 0.05 % to 5% by weight, and preferably ranging from 0.1% to 2% by weight, and preferably ranging from 0.2% to 1.5% by weight.
  • composition according to the invention comprises at least one nonionic or anionic polymer.
  • nonionic or anionic polymer or polymers according to the invention are especially chosen from:
  • celluloses preferably hydroxyalkyl (C 1 -C 4) celluloses and hydroxyalkyl (C 1 -C 4) alkyl (C 1 -C 4) celluloses,
  • polyvinylpyrrolidones of different molecular weights, the weight average molecular weight of said homopolymer being measured by diffraction of light.
  • polyvinylpyrrolidones are chosen from polyvinylpyrrolidones having a weight average molecular weight ranging from 2000 Daltons to 3000000 Daltons, more particularly having a weight average molecular weight ranging from 30000 Daltons to 2000000 Daltons, preferably having a molecular weight. average in weight ranging from 40000 Daltons to 1500000 Daltons.
  • said homopolymer (s) and copolymer (s) of vinylpyrrolidone present in the composition is chosen from polyvinylpyrrolidone having a weight average molecular weight ranging from 40000 Daltons to 80000 Daltons, and polyvinylpyrrolidone having a weight average molecular weight of from 900000 Daltons to 1500000 Daltons.
  • a polyvinylpyrrolidone according to the invention is available under the trade name PVP K 30L® from the company ISP.
  • a polyvinylpyrrolidone according to the invention is available under the trade name PVP K 90® from the ISP company (ASHLAND.
  • any type of vinylpyrrolidone copolymer can be used.
  • copolymer refers to polymers resulting from the polymerization of vinylpyrrolidone with a single type of monomer, as those resulting from the polymerization of vinylpyrrolidone with several kinds of monomers, and for example with two kinds of monomers leading to the production of of terpolymer.
  • polyvinylpyrrolidone / vinyl acetate copolymers PVPA A
  • polyvinylpyrrolidone / butene copolymers PVPA A
  • polyvinylpyrrolidone / decene polyvinylpyrrolidone / hexadecene
  • polyvinylpyrrolidone / vinyl acetate / itaconic acid polyvinylpyrrolidone / vinyl acetate / vinyl propionate.
  • the homo- and copolymers are chosen from polyvinylpyrrolidones (PVP) and vinylpyrrolidone / vinyl acetate copolymers (PVPA / A).
  • copolymers are commercially available, for example under the trademark LUVISKOL® (PVP and PVPA / A) from BASF and under the names PVP-K or PVPA / A from ISP.
  • the polyvinyl alcohols are chosen in particular from PVA having a weight average molecular weight ranging from 10,000 Daltons to 200,000 Daltons, more particularly having a weight average molecular weight ranging from 100,000 Daltons to 200,000 Daltons.
  • the polyvinyl alcohols according to the invention can have polymers of different degrees of hydrolysis and / or different viscosities.
  • polyvinyl alcohol having a degree of hydrolysis varying from 74 to 99% and / or having a viscosity ranging from 2.6 to 67 cps (2.6 to 67 mPa.s) can be used.
  • polyvinyl alcohol mention may be made for example the product available under the trade name CELVOL 205 PV ALCOHOL® from Sekisui Specialty Chemicals.
  • the celluloses that can be used according to the invention are for example chosen from
  • hydroxypropyl methylcelluloses sold especially under the names METHOCEL F4M STANDARD or METHOCEL K 15M by the company DOW CHEMICAL;
  • methylcelluloses for example sold under the name TYLOSE MH 200 KG4 by CLARIANT;
  • hydroxyethylcelluloses for example sold under the name NATROSOL 250 HHR by the company ASHLAND
  • hydroxypropylcelluloses for example sold under the name "KLUCEL H” by the company ASHLAND;
  • hydroxyethyl methylcelluloses for example sold under the name "TYLOSE MH 300" by the company HOECHST
  • the polymers containing sulphonic groups are homo or copolymers that can be obtained from at least one ethylenically unsaturated monomer containing a sulphonic group, which can be in free form or partially or totally neutralized.
  • the polymers in accordance with the invention may be partially or completely neutralized with a mineral base (sodium hydroxide, potassium hydroxide, aqueous ammonia) or an organic base such as mono-, di- or tri-ethanolamine, aminomethylpropanediol, N methyl glucamine, basic amino acids such as arginine and lysine, and mixtures of these compounds. They are usually neutralized.
  • the term "neutralized” in the present invention means polymers that are totally or substantially completely neutralized, that is to say neutralized to at least 90%.
  • the polymers used in the composition of the invention generally have a number-average molecular weight ranging from 1000 to 20,000,000 g / mol, preferably from 20,000 to 5,000,000 and even more preferably from 100,000 to 1,500,000. g / mol.
  • These polymers according to the invention may be crosslinked or non-crosslinked.
  • the monomers containing sulphonic groups of the polymer used in the composition of the invention are chosen in particular from vinylsulphonic acid, styrenesulphonic acid, (meth) acrylamido (C 1 -C 22 ) alkylsulphonic acids, N- (dC) acids. 22 ) alkyl- (meth) acrylamido (C 1 -C 22 ) alkylsulfonic acid such as undecyl-acrylamido-methane- sulfonic acid, as well as their partially or totally neutralized forms, and their mixtures.
  • the monomers containing a sulphonic group are chosen from (meth) acrylamido (Ci-C 2 2) alkylsulphonic acids, such as, for example, acrylamido-methanesulfonic acid and acrylamido acid.
  • ethanesulfonic acid acrylamido-propanesulfonic acid, 2-acrylamido-2-methylpropanesulfonic acid, 2-methacrylamido-2-methylpropanesulfonic acid, 2-acrylamido-n-butane sulfonic acid, 2-acrylamido-2,4,4-trimethylpentanesulfonic acid, 2-methacrylamido-dodecylsulphonic acid, 2-acrylamido-2,6-dimethyl-3-heptanesulfonic acid, as well as their partially or completely neutralized forms, and their mixtures.
  • APMS 2-acrylamido-2-methylpropanesulfonic acid
  • the crosslinking agents may be chosen from the olefinically-polyunsaturated compounds commonly used for crosslinking the polymers obtained by radical polymerization.
  • the crosslinking agent is chosen from methylene-bis-acrylamide, allyl methacrylate or trimethylol propane triacrylate (TMPTA).
  • TMPTA trimethylol propane triacrylate
  • the degree of crosslinking generally ranges from 0.01 to 10 mol% and more particularly from 0.2 to 2 mol% relative to the polymer.
  • the homopolymer of monomers containing sulfonic groups may be crosslinked with one or more crosslinking agents.
  • These homopolymers are generally crosslinked and neutralized.
  • polymers with sulfonic groups mention may be made in particular of the crosslinked and neutralized homopolymer of 2-acrylamido-2-methylpropanesulphonic acid, marketed by the company Clariant under the trademark "Hostacerin® AMPS” (CTFA name: ammonium polyacryldimethyltauramide).
  • the nonionic or anionic polymer (s) may be present at a content ranging from 0.01% to 15% by weight, preferably ranging from 0.1% to 10% by weight, relative to the total weight of the composition.
  • the celluloses and the polymers of monomers containing a sulfonic group may be present in a content ranging from 0.01% to 5% by weight, preferably ranging from 0.1% to 2%. by weight, more preferably from 0.2% to 1% by weight, relative to the total weight of the composition.
  • the PVP polymer (s) and polyvinyl alcohol (s) can be present in a content ranging from 0.1% to 10% by weight, preferably ranging from 1% to 5% by weight. , relative to the total weight of the composition.
  • the mass ratio of the said polymer / compound of formula (I) present in the composition according to the invention is preferably from 0.1 to 15, for example ranging from 1 to 10.
  • composition according to the present invention comprises at least one glycol.
  • glycol is meant a hydrocarbon chain comprising at least 2 carbon atoms, preferably 2 to 50 carbon atoms, preferably 2 to 20 carbon atoms, preferably having 2 to 10 carbon atoms, and preferably having from 2 to 6 carbon atoms, and bearing two hydroxyl groups.
  • the glycols used in the present invention may have a weight average molecular weight less than or equal to 1000, preferably between 60 and 500.
  • the glycol may be a natural or synthetic glycol.
  • the glycol may have a linear, branched or cyclic structure.
  • the glycol may be chosen from diethylene glycol, propylene glycol, dipropylene glycol, butylene glycol, pentylene glycol, hexylene glycol, 1,3-propanediol, 1,5-pentanediol and polyethylene glycols, especially having 5 to 50 ethylene oxide groups, and mixtures thereof.
  • the glycol may be chosen from the group consisting of dipropylene glycol, propylene glycol, propanediol-1, 3, butylene glycol, and their mixture, and more particularly dipropylene glycol.
  • the said glycol (s) may be present in a content ranging from 0.50% to 50% by weight, relative to the total weight of the composition, preferably ranging from 3% to 30% by weight. % by weight, and preferably ranging from 5% to 20% by weight, relative to the total weight of the composition.
  • the composition according to the present invention comprises water.
  • the amount of water is not limited, and may range from 50% to 99% by weight, preferably from 55% to 95% by weight, and more preferably from 70% to 90% by weight, based on weight. total of the composition.
  • composition according to the present invention further comprises at least one C2-C4 monoalcohol.
  • C2-C4 monoalcohols comprise a hydroxy group and 2 to 4 carbon atoms. Ethanol, propanol, isopropanol, butanol-1, isobutanol and mixtures thereof can be used.
  • the C2-C4 monoalcohol is preferably ethanol.
  • the concentration of C2-C4 monoalcohol can range from 0.1% to 30% by weight, preferably from 0.5% to 15% by weight, relative to the total weight of the composition.
  • compositions used according to the invention may comprise a physiologically acceptable medium, that is to say a medium which is suitable for the topical administration of a composition, that is to say compatible with the keratinous substances of the present invention.
  • a physiologically acceptable medium that is to say a medium which is suitable for the topical administration of a composition, that is to say compatible with the keratinous substances of the present invention.
  • human beings such as the skin, the scalp, the hair, the nails.
  • a physiologically acceptable medium is preferably a cosmetically acceptable medium, that is to say without odor, or unpleasant appearance, and which is perfectly compatible with the topical route of administration.
  • the term "keratin materials" according to the invention is understood to mean the skin, the body, the face and / or the contour of the eyes, the lips, the nails, the mucous membranes, the eyelashes, the eyebrows, the hairs, the scalp and / or the hair, or any other skin area of the body. More particularly, the keratin materials according to the invention are the scalp, the hair, and / or the skin.
  • the keratin materials according to the invention are the scalp and / or the hair.
  • the keratin materials according to the invention is the skin.
  • skin is meant all of the skin of the body, and preferably, the skin of the face, beaulleté, neck, arms and forearms, or even more preferably, the skin of the skin. face, including forehead, nose, cheeks, chin, eye area.
  • the compound of formula (I) is advantageously present in the compositions according to the invention in a solubilized form.
  • the composition according to the invention may be intended to be administered topically, that is to say by surface application of the keratin material in question, such as the skin under consideration.
  • the composition of the invention may be a cosmetic composition (either intended for cosmetic use) or dermatological.
  • the composition is a cosmetic composition and even more preferentially a cosmetic composition for topical application.
  • cosmetic composition is understood to mean a substance or a preparation intended to be brought into contact with the various superficial parts of the human body, in particular the epidermis, the hair and hair systems, the nails, the lips and the oral mucosa, in particular view, exclusively or mainly, to clean, embellish, perfume, change the appearance, protect, maintain or repair body odors.
  • compositions according to the invention may be in the form of aqueous solutions, hydroalcoholic solutions, oil-in-water (O / W) or water-in-oil (W / O) or multiple (triple: E / W) emulsions. H / E or H / E / H), aqueous gels. These compositions are prepared according to the usual methods.
  • the composition may comprise at least one oil.
  • oils there may be mentioned for example:
  • hydrocarbon-based oils of vegetable origin such as liquid triglycerides of fatty acids containing from 4 to 10 carbon atoms, for instance triglycerides of heptanoic or octanoic acids or, for example, sunflower, corn or soybean oils, squash, grape seed, sesame, hazelnut, apricot, macadamia, arara, castor oil, avocado, triglycerides of caprylic / capric acids such as those sold by Stearineries Dubois or those sold under the names "Miglyol 810", “812" and "818" by Dynamit Nobel, jojoba oil, shea butter oil;
  • liquid triglycerides of fatty acids containing from 4 to 10 carbon atoms for instance triglycerides of heptanoic or octanoic acids or, for example, sunflower, corn or soybean oils, squash, grape seed, sesame, hazelnut, apricot, macadamia, ar
  • esters and synthetic ethers in particular of fatty acids, such as the oils of formulas R 1 COOR 2 and R 10 R 2 in which R 1 represents the residue of a fatty acid comprising from 8 to 29 carbon atoms, and R 2 represents a hydrocarbon-based chain , branched or unbranched, containing from 3 to 30 carbon atoms, for example purcellin oil, isononyl isononanoate, isopropyl myristate, 2-ethylhexyl palmitate, stearate of octyl-2-dodecyl, octyl-2-dodecyl erucate, isostearyl isostearate; hydroxylated esters such as isostearyl lactate, octyl hydroxystearate, octyldodecyl hydroxystearate, diisostearyl malate, triisocetyl citrate; heptanoates, octano
  • linear or branched hydrocarbons of mineral or synthetic origin such as paraffin oils, volatile or not, and their derivatives, petroleum jelly, polydecenes, hydrogenated polyisobutene such as sesam oil;
  • fatty alcohols having from 8 to 26 carbon atoms such as cetyl alcohol, stearyl alcohol and their mixture (cetylstearyl alcohol), octyldodecanol, 2-butyloctanol, 2-hexyldecanol, 2-undecylpentadecanol, oleic alcohol or linoleic alcohol;
  • silicone oils such as volatile or non-volatile polymethylsiloxanes (PDMS) with a linear or cyclic silicone chain, which are liquid or pasty at room temperature, in particular cyclopolydimethylsiloxanes (cyclomethicones) such as cyclohexasiloxane; polydimethylsiloxanes comprising alkyl, alkoxy or phenyl groups, during or at the end of the silicone chain, groups having from 2 to 24 carbon atoms; phenyl silicones such as phenyltrimethicones, phenyldimethicones, phenyltrimethylsiloxydiphenylsiloxanes, diphenyl-dimethicones, diphenylmethyldiphenyltrisiloxanes, 2-phenylethyltrimethylsiloxysilicates, and polymethylphenylsiloxanes;
  • PDMS volatile or non-volatile polymethylsiloxanes
  • hydrocarbon-based oil in the list of oils mentioned above, any oil predominantly comprising carbon and hydrogen atoms, and optionally ester, ether, fluoro, carboxylic acid and / or alcohol groups.
  • the composition according to the invention may comprise solid bodies at ambient temperature (25 ° C.), for example fatty acids containing from 8 to 30 carbon atoms, such as stearic acid, lauric acid and palmitic acid. and oleic acid; waxes such as lanolin, beeswax, carnauba or candelilla wax, paraffin waxes, microcrystalline waxes, ceresin or ozokerite, synthetic waxes such as polyethylene waxes, Fischer waxes, Tropsch.
  • the composition according to the invention is a water-in-oil (W / O) or oil-in-water (O / W) emulsion.
  • W / O water-in-oil
  • O / W oil-in-water
  • the proportion of the oily phase of the emulsion may range from 1% to 80% by weight, and preferably from 5% to 50% by weight relative to the total weight of the composition.
  • the emulsions generally contain at least one emulsifier, especially chosen from amphoteric, anionic, cationic or nonionic emulsifiers, used alone or as a mixture, and optionally a co-emulsifier.
  • the emulsifiers are suitably selected according to the emulsion to be obtained (W / O or O / W).
  • the emulsifier and the co-emulsifier are generally present in the composition, in a proportion ranging from 0.3 to 30% by weight, and preferably from 0.5 to 20% by weight relative to the total weight of the composition.
  • emulsifiers examples include dimethicone copolyols such as the mixture of cyclomethicone and dimethicone copolyol, sold under the name "DC 5225 C” by the company Dow Corning, and the alkyl-dimethicone copolyols such as Laurylmethicone copolyol sold under the name "Dow Corning 5200 Formulation Aid” by the company Dow Corning and Cetyl dimethicone copolyol sold under the name "Abil EM 90®” by the company Goldschmidt.
  • dimethicone copolyols such as the mixture of cyclomethicone and dimethicone copolyol, sold under the name "DC 5225 C” by the company Dow Corning
  • alkyl-dimethicone copolyols such as Laurylmethicone copolyol sold under the name "Dow Corning 5200 Formulation Aid” by the company Dow Corning
  • emulsifiers for example, of nonionic emulsifiers such as oxyalkylenated (more particularly polyoxyethylenated) fatty acid esters of glycerol; oxyalkylenated fatty acid and sorbitan esters; oxyalkylenated fatty acid esters (oxyethylenated and / or oxypropylenated); oxyalkylenated fatty alcohol ethers (oxyethylenated and / or oxypropylenated); sugar esters such as sucrose stearate; and mixtures thereof such as the mixture of glyceryl stearate and PEG-100 stearate.
  • nonionic emulsifiers such as oxyalkylenated (more particularly polyoxyethylenated) fatty acid esters of glycerol; oxyalkylenated fatty acid and sorbitan esters; oxyalkylenated fatty acid esters (oxyethy
  • the composition may be an aqueous gel, and in particular comprise conventional aqueous gelling agents.
  • the composition according to the invention may also contain adjuvants which are customary in the cosmetic or dermatological field, such as gelling agents, thickeners, film-forming polymers, preservatives, perfumes, fillers, UV filters, bactericidal agents, odor absorbers, dyestuffs, plant extracts, vitamins, polyols such as glycerin, sugars such as sorbitol, cosmetic and dermatological active ingredients, and salts.
  • adjuvants which are customary in the cosmetic or dermatological field, such as gelling agents, thickeners, film-forming polymers, preservatives, perfumes, fillers, UV filters, bactericidal agents, odor absorbers, dyestuffs, plant extracts, vitamins, polyols such as glycerin, sugars such as sorbitol, cosmetic and dermatological active ingredients, and salts.
  • the amounts of these various adjuvants are those conventionally used in the field under consideration, and for example from 0.001 to 20% of the total weight of the
  • composition preferably comprises glycerin.
  • the composition according to the invention has a pH ranging from 3 to 7.
  • the pH of the composition ranges from 4 to 6.
  • the subject of the invention is also a process for the cosmetic treatment of skincare, makeup, and / or cleaning of keratinous substances, in particular the skin, comprising the application on said keratin materials, in particular the skin, of a composition according to the invention as described above.
  • Said method of cosmetic treatment of care, makeup, and / or cleansing of the skin is non-therapeutic.
  • the subject of the invention is also a cosmetic process for the depigmentation, lightening and / or bleaching of keratin materials, in particular human skin, hair or hair, comprising the application to said keratin materials of a composition according to the invention. invention as described above.
  • the subject of the invention is also a cosmetic process for preventing and / or treating cutaneous signs of aging, comprising at least one step of topical application to keratin materials, such as the skin, of a composition according to the invention as previously described.
  • the cutaneous signs of the aging to be prevented and / or treated in the cosmetic process according to the invention may be chosen from the lines and wrinkles, and / or to fight against the skin withered, soft and / or thinned.
  • the invention also relates to the cosmetic use of a composition according to the invention as defined above, for the care, makeup and / or cleaning of keratin materials.
  • the invention relates to a cosmetic treatment method for the care, makeup, and / or cleaning of keratinous substances, in particular the skin, comprising the administration, topically, to an individual, of a composition as defined above.
  • compositions according to the invention are given by way of illustration and without limitation.
  • the compounds are indicated in chemical name or INCI name.
  • the contents of the ingredients are expressed in percentage by weight.
  • Example 1 Evaluation of the stability of formulations Method of preparation :
  • the polymer (homopolymer of vinylpyrrolidone (PVP)) is mixed in the water simply by contacting with magnetic stirring at room temperature.
  • the solution of compound 1 in dipropylene glycol is then prepared by heating at about 50 ° C for about 10 minutes with magnetic stirring.
  • the polymer solution is poured into the water at room temperature.
  • the stability of the obtained preparation stored at 4 ° C. and at room temperature after 24 hours is evaluated by a macroscopic examination with the eye (observation or not of a cloudiness or a deposit) and by observation under a microscope under a light. polarized (presence or absence of crystals) and after 2 months of storage.
  • compositions 1A, 1B, and 1C in accordance with the invention are stable at room temperature and at 4 ° C., and show no recrystallization of compound 1, this resorcinol derivative is so very well solubilized in these particular associations.
  • the hydrophobic compounds are heated independently of those of the hydrophilic phase at 70 ° C.
  • the oil phase is added to the water phase with stirring and then the thickeners and the volatile compounds are added.
  • composition is stable and homogeneous after storage for 1 month at 45 ° C.
  • This composition can be applied regularly to the skin of the face to reduce the signs of skin aging and lighten the skin.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to a composition comprising: at least one 4-(heterocycloalkyl)-benzene-1,3-diol compound; at least one anionic or non-ionic polymer; at least one glycol; and water. The invention also relates to the use of the composition for making-up, caring for and/or cleaning keratin materials, in particular the skin.

Description

Composition aqueuse comprenant un composé 4-(hétérocycloalkyl)-benzène-1 ,3- diol, un polymère et un glycol  An aqueous composition comprising a 4- (heterocycloalkyl) -benzene-1,3-diol compound, a polymer and a glycol
La présente invention a pour objet une composition, de préférence cosmétique, comprenant un composé 4-(hétérocycloalkyl)-benzène-1 ,3-diol, un polymère et au moins un glycol. The subject of the present invention is a composition, preferably a cosmetic composition, comprising a 4- (heterocycloalkyl) -benzene-1,3-diol compound, a polymer and at least one glycol.
Les dérivés de 4-(hétérocycloalkyl)-benzène-1 ,3-diol sont des composés utilisés pour le traitement des signes cutanés du vieillissement et plus particulièrement comme agent dépigmentant des matières kératiniques. The 4- (heterocycloalkyl) -benzene-1,3-diol derivatives are compounds used for the treatment of cutaneous signs of aging and more particularly as a depigmenting agent for keratin materials.
Toutefois, ces composés qui se présentent sous forme solide à température ambiante et ont un point de fusion élevé (>210°C) sont difficiles à solubiliser. Ils sont notamment faiblement solubles dans l'eau et la glycérine. However, these compounds which are in solid form at room temperature and have a high melting point (> 210 ° C) are difficult to solubilize. They are notably poorly soluble in water and glycerine.
Or, il nécessaire que ces composés soient formulés sous une forme solubilisée, et notamment à une teneur forte, telle que supérieure ou égale à 0,20% en poids, afin de tirer au mieux profit de leur activité et il est également préférable que leur solubilisation soit maintenue au cours du temps pour éviter tout phénomène de recristallisation lors du stockage des compositions comprenant de tels composés. However, it is necessary that these compounds be formulated in a solubilized form, and in particular at a high content, such as greater than or equal to 0.20% by weight, in order to make the most of their activity and it is also preferable that their solubilization is maintained over time to avoid any recrystallization phenomenon during the storage of compositions comprising such compounds.
En effet les formes solubilisées conduisent à une meilleure biodisponibilité dans la peau que des formes cristallisées dont la taille des cristaux est mal contrôlée. In fact the solubilized forms lead to a better bioavailability in the skin than crystallized forms whose crystal size is poorly controlled.
Par "biodisponibilité", on entend au sens de la présente demande la pénétration moléculaire de l'actif concerné dans les couches vivantes de la peau et en particulier de l'épiderme. On cherchera à ce que la concentration pénétrée soit la plus élevée possible, de façon à augmenter le taux d'actif arrivant jusqu'aux couches vivantes de la peau. For the purposes of this application, the term "bioavailability" refers to the molecular penetration of the active agent into the living layers of the skin and in particular of the epidermis. It will be sought that the penetrated concentration is as high as possible, so as to increase the rate of asset reaching the living layers of the skin.
Par "forme solubilisée", on entend une dispersion des dérivés selon l'invention dans un liquide, à l'état moléculaire libre, en particulier sous forme non complexée. Aucune cristallisation des dérivés 4-(hétérocycloalkyl)-benzène-1 ,3-diol n'est visible à l'œil nu ou en microscopie optique en polarisation croisée. By "solubilized form" is meant a dispersion of the derivatives according to the invention in a liquid, in the free molecular state, in particular in uncomplexed form. No crystallization of 4- (heterocycloalkyl) -benzene-1,3-diol derivatives is visible to the naked eye or in cross-polarized light microscopy.
Les compositions contenant un taux élévé de glycols apportent un toucher de la peau collant et gras. On cherche donc à augmenter la solubilité de ces actifs mais en utilisant des quantités limitées de solvants qui diminuent les propriétés cosmétiques des compositions.  Compositions containing a high level of glycols provide a tacky and greasy feel of the skin. It is therefore sought to increase the solubility of these active ingredients but using limited quantities of solvents which reduce the cosmetic properties of the compositions.
La présente invention a précisément pour objet de proposer une nouvelle formulation galénique des composés 4-(hétérocycloalkyl)-benzène-1 ,3-diol permettant de s'affranchir des inconvénients précités, et donc d'incorporer ces composés sous une forme solubilisée et durable dans le temps, ces composés étant notamment présent à une forte teneur (telle qu'une teneur supérieure ou égale à 0,20% en poids par rapport au poids total de la composition). Cette nouvelle formulation galénique des composés 4- (hétérocycloalkyl)-benzène-l ,3-diol permet notamment d'améliorer l'efficacité de l'actif pour le traitement des matières kératiniques telles que la peau. Les compositions selon l'invention permettent d'utiliser des quantités inférieures de glycols. The object of the present invention is precisely to propose a novel galenic formulation of the 4- (heterocycloalkyl) -benzene-1,3-diol compounds making it possible to overcome of the abovementioned disadvantages, and therefore to incorporate these compounds in a solubilized form and durable over time, these compounds being in particular present at a high content (such as a content greater than or equal to 0.20% by weight relative to the weight total of the composition). This new galenic formulation of the compounds 4- (heterocycloalkyl) -benzene-1,3-diol makes it possible in particular to improve the efficacy of the active ingredient for the treatment of keratin materials such as the skin. The compositions according to the invention make it possible to use lower amounts of glycols.
Les inventeurs ont en effet découvert, de façon inattendue, que l'association d'au moins un composé 4-(hétérocycloalkyl)-benzène-1 ,3-diol avec au moins un glycol et au moins un polymère non ionique ou anionique permet de solubiliser ce composé tout en évitant sa recristallisation, notamment après un stockage d'au moins 1 semaine, voire 1 mois, 2 mois ou plus à température ambiante (25 °C) et/ou à 4°C et/ou à 45°C. De façon plus précise, l'invention a pour objet une composition, notamment cosmétique, comprenant ; The inventors have in fact unexpectedly discovered that the combination of at least one 4- (heterocycloalkyl) -benzene-1,3-diol compound with at least one glycol and at least one nonionic or anionic polymer makes it possible to solubilize this compound while avoiding recrystallization, especially after storage for at least 1 week, or even 1 month, 2 months or more at room temperature (25 ° C) and / or at 4 ° C and / or 45 ° C . More specifically, the subject of the invention is a composition, in particular a cosmetic composition, comprising;
- au moins un polymère non ionique ou anionique ;  at least one nonionic or anionic polymer;
- au moins un glycol ;  at least one glycol;
- de l'eau,  - some water,
- au moins un composé 4-(hétérocycloalkyl)-benzène-1 ,3-diol de formule (I); at least one 4- (heterocycloalkyl) -benzene-1,3-diol compound of formula (I);
tels que définis ci-après. as defined below.
La présente invention concerne également un procédé de préparation d'une telle composition comprenant les étapes suivantes : The present invention also relates to a process for preparing such a composition comprising the following steps:
1 ) préparation d'une solution A par le mélange d'au moins un polymère non ionique ou anionique et de l'eau, et 1) preparing a solution A by mixing at least one nonionic or anionic polymer and water, and
2) préparation d'une solution B par le mélange d'au moins un composé 4- (hétérocycloalkyl)-benzène-l ,3-diol dans au moins un glycol, puis  2) preparing a solution B by mixing at least one 4- (heterocycloalkyl) -benzene-1,3-diol compound in at least one glycol, and
3) mélange des solutions A et B  3) mixing solutions A and B
De préférence l'étape 1 ) dudit procédé est la préparation d'une solution A par le mélange d'au moins un polymère selon l'invention et de l'eau par simple mise en contact sous agitation ( par exemple agitation magnétique) à température ambiante (20-25°C) . De préférence l'étape 2) dudit procédé est la préparation d'une solution B par le mélange d'au moins un composé 4-(hétérocycloalkyl)-benzène-1 ,3-diol dans au moins un glycol par chauffage, notamment en chauffant à une température de 40-60°C, de préférence à environ 50°C, pendant environ 10 minutes sous agitation (par exemple magnétique). De préférence l'étape 3) dudit procédé est le mélange des solutions A et B par versement de la solution A sur la solution B à température ambiante. Preferably step 1) of said process is the preparation of a solution A by mixing at least one polymer according to the invention and water by simply contacting with stirring (for example magnetic stirring) at room temperature. ambient temperature (20-25 ° C). Preferably step 2) of said process is the preparation of a solution B by the mixture of at least one 4- (heterocycloalkyl) -benzene-1,3-diol compound in at least one glycol by heating, in particular by heating at a temperature of 40-60 ° C, preferably at about 50 ° C, for about 10 minutes with stirring (eg magnetic). Preferably step 3) of said process is the mixture of solutions A and B by pouring solution A on solution B at room temperature.
Particulièrement la présente invention concerne un procédé de préparation d'une telle composition comprenant les étapes suivantes : In particular, the present invention relates to a process for preparing such a composition comprising the following steps:
1 ) préparation d'une solution A par le mélange d'au moins un polymère selon l'invention et de l'eau, notamment par simple mise en contact sous agitation (par exemple agitation magnétique) à température ambiante (20-25°C), et  1) preparation of a solution A by mixing at least one polymer according to the invention and water, in particular by simple contact with stirring (for example magnetic stirring) at room temperature (20-25 ° C. ), and
2) préparation d'une solution B par le mélange d'au moins un composé 4- (hétérocycloalkyl)-benzène-l ,3-diol dans au moins un glycol, de préférence par chauffage, notamment en chauffant à une température de 40-60°C, de préférence à environ 50°C, pendant environ 10 minutes sous agitation (par exemple magnétique) ; puis 2) preparing a solution B by mixing at least one 4- (heterocycloalkyl) -benzene-1,3-diol compound in at least one glycol, preferably by heating, in particular by heating to a temperature of 40- 60 ° C, preferably at about 50 ° C, for about 10 minutes with stirring (eg magnetic); then
3) mélange des solutions A et B, de préférence par versement de la solution A sur la solution B à température ambiante. 3) mixing solutions A and B, preferably by pouring solution A on solution B at room temperature.
Les étapes 1 et 2 dudit procédé peuvent être mises en œuvre dans un ordre quelconque.  Steps 1 and 2 of said method can be implemented in any order.
Les composés 4-(hétérocycloalkyl)-benzène-1 ,3-diol selon l'invention sont de formule générale (I) suivante : The 4- (heterocycloalkyl) -benzene-1,3-diol compounds according to the invention have the following general formula (I):
Figure imgf000004_0001
dans laquelle
Figure imgf000004_0001
in which
R1 , R2, R3, R4, identiques ou différents, représentent :  R1, R2, R3, R4, which may be identical or different, represent:
- un hydrogène  - a hydrogen
- un radical alkyle en C1 -C4  a C1-C4 alkyl radical
- un hydroxyméthyle, un hydroxyethyle,  a hydroxymethyl, a hydroxyethyl,
- un alkoxy C1 -C4 carbonyle,  a C1-C4 alkoxycarbonyl,
- un alkoxy C1 -C4,  a C1-C4 alkoxy,
- un hydroxyle  - a hydroxyl
ou or
R1 et R2 sont reliés entre eux et forment un cycle carboné à 5 ou 6 atomes de carbone avec l'atome de carbone auquel ils sont liés et R3 et R4, identiques ou différents, représentent : - un hydrogène R1 and R2 are interconnected and form a carbon ring with 5 or 6 carbon atoms with the carbon atom to which they are bonded and R3 and R4, identical or different, represent: - a hydrogen
- un radical alkyle en C1 -C4  a C1-C4 alkyl radical
ou R1 et R4 sont reliés entre eux et forment une chaîne -(CH2)2- ou -(CH2)3- et R2 et R3, identiques ou différents, représentent : or R1 and R4 are connected together and form a chain - (CH2) 2 - or - (CH2) 3 - and R2 and R3, which may be identical or different, represent:
- un hydrogène  - a hydrogen
- un radical alkyle en C1 -C4 X représente un atome d'oxygène, ou un atome de soufre.  a C1-C4 alkyl radical X represents an oxygen atom, or a sulfur atom.
Y représente un hydrogène, un atome de chlore ou un atome de fluor.  Y represents a hydrogen, a chlorine atom or a fluorine atom.
m peut prendre les valeurs 1 ou 2 et n peut prendre les valeurs 0 ou 1 et lorsque n=0, alors m=1 ou 2, et lorsque n=1 , alors m=1 . ainsi que les sels des composés de formule générale (I), et leurs formes isomères et énantiomères. m can take the values 1 or 2 and n can take the values 0 or 1 and when n = 0, then m = 1 or 2, and when n = 1, then m = 1. as well as the salts of the compounds of general formula (I), and their isomeric and enantiomeric forms.
Parmi les sels des composés de formule générale (I), on peut citer de préférence les sels avec une base organique ou avec une base inorganique. Among the salts of the compounds of general formula (I), there may be mentioned preferably salts with an organic base or with an inorganic base.
Les bases inorganiques appropriées sont par exemple l'hydroxyde de potassium, l'hydroxyde de sodium ou l'hydroxyde de calcium. Suitable inorganic bases are, for example, potassium hydroxide, sodium hydroxide or calcium hydroxide.
Les bases organiques appropriées sont par exemple la morpholine, la piperazine, l'arginine, la lysine. Les composés de formule générale (I), peuvent également exister sous formes d'hydrates ou de solvates.  Suitable organic bases are, for example, morpholine, piperazine, arginine, lysine. The compounds of general formula (I) may also exist in the form of hydrates or solvates.
Les solvants appropriés pour former des solvates sont par exemple les alcools comme l'éthanol ou l'iso-propanol. Selon la présente invention, on désigne par alkyle en C1 -C4 une chaîne hydrocarbonée saturée, linéaire ou ramifiée, comprenant de 1 à 4 atomes de carbone.  Suitable solvents for forming solvates are, for example, alcohols such as ethanol or iso-propanol. According to the present invention, the term C1-C4 alkyl denotes a saturated hydrocarbon chain, linear or branched, comprising from 1 to 4 carbon atoms.
Selon la présente invention, on désigne par aikoxy C1 -C4 carbonyle un radical carboxy substitué par un radical alkyle comprenant de 1 à 4 atomes de carbone. According to the present invention, C1-C4 alkyloxycarbonyl denotes a carboxy radical substituted with an alkyl radical containing from 1 to 4 carbon atoms.
Selon la présente invention, on désigne par aikoxy C1 -C4 un atome d'oxygène substitué par une chaîne hydrocarbonée saturée, linéaire ou ramifiée, comprenant de 1 à 4 atomes de carbone. Selon la présente invention, on désigne par isomères les formes cis et trans relatives aux substituants sur l'heterocycloalkyle en position 4 du benzène -1 ,3-diol. According to the present invention, C1-C4 alkoxy denotes an oxygen atom substituted by a linear or branched saturated hydrocarbon-based chain containing from 1 to 4 carbon atoms. According to the present invention, the isomers are the cis and trans forms relating to the substituents on the heterocycloalkyl at the 4-position of benzene-1,3-diol.
Selon la présente invention, les composés de formule générale (I) particulièrement préférés sont ceux pour lesquels: According to the present invention, the compounds of general formula (I) that are particularly preferred are those for which:
- R1 représente un hydrogène, un radical alkyle en C1 -C4 ou un radical hydroxyméthyle, R1 represents a hydrogen, a C1-C4 alkyl radical or a hydroxymethyl radical,
- R2 représente un hydrogène, R2 represents a hydrogen,
- R3 représente un hydrogène,  R3 represents a hydrogen,
- R4 représente un hydrogène,  R4 represents a hydrogen,
- X représente un atome d'oxygène X represents an oxygen atom
- Y représente un hydrogène ou un atome de fluor  Y represents a hydrogen or a fluorine atom
- m = 1 et n = 1 , ainsi que les sels de ces composés de formule générale (I), et leurs formes isomères et énantiomères.  m = 1 and n = 1, as well as the salts of these compounds of general formula (I), and their isomeric and enantiomeric forms.
Parmi les composés de formule (I) entrant dans le cadre de la présente invention, on peut notamment citer les suivants : Among the compounds of formula (I) falling within the scope of the present invention, mention may be made in particular of the following:
I : 4-(tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  I: 4- (tetrahydro-pyran-4-yl) -benzene-1,3-diol
2 : 4-(tétrahydro-thiopyran-4-yl)-benzène-1 ,3-diol 2: 4- (tetrahydro-thiopyran-4-yl) -benzene-1,3-diol
3: 4-( cis-2,6-Diméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  3: 4- (cis-2,6-Dimethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
4 : trans-4-(2-méthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  4: trans-4- (2-methyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
5 : cis-4-(2-méthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  5: cis-4- (2-methyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
6 : trans-4-(2-Ethyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  6: trans-4- (2-Ethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
7 : cis-4-(2-Ethyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol 7: cis-4- (2-Ethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
8 : trans-4-(2-Hydroxyméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  8: trans-4- (2-Hydroxymethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
9 : 4-(2,2,6,6-tétraméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  9: 4- (2,2,6,6-tetramethyltetrahydro-pyran-4-yl) benzene-1,3-diol
10 : 4-(tétrahydro-furan-3-yl)-benzène-1 ,3-diol  10: 4- (tetrahydro-furan-3-yl) -benzene-1,3-diol
I I : 4-(tétrahydro-thiophen-3-yl)-benzène-1 ,3-diol  I: 4- (tetrahydro-thiophen-3-yl) -benzene-1,3-diol
12 : 4-(6-Oxa-spiro[4.5]dec-9-yl)-benzène-1 ,3-diol 12: 4- (6-Oxa-spiro [4.5] dec-9-yl) -benzene-1,3-diol
13 : 4-Chloro-6-(tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  13: 4-Chloro-6- (tetrahydro-pyran-4-yl) -benzene-1,3-diol
14 : 4-Fluoro-6-(tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  14: 4-Fluoro-6- (tetrahydro-pyran-4-yl) -benzene-1,3-diol
15 : 4-(2,2-Diethyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  15: 4- (2,2-Diethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
16 : 4-(tétrahydro-pyran-3-yl)-benzène-1 ,3-diol  16: 4- (tetrahydro-pyran-3-yl) -benzene-1,3-diol
17 : trans-4-(5-Hydroxyméthyl-tétrahydro-furan-3-yl)-benzène-1 ,3-diol 17: trans-4- (5-Hydroxymethyl-tetrahydro-furan-3-yl) -benzene-1,3-diol
18 : cis-4-(5-Hydroxyméthyl-tétrahydro-furan-3-yl)-benzène-1 ,3-diol  18: cis-4- (5-Hydroxymethyl-tetrahydro-furan-3-yl) -benzene-1,3-diol
19 : trans-4-Fluoro-6-(5-hydroxyméthyl-tétrahydro-furan-3-yl)-benzène-1 ,3-diol  19: trans-4-Fluoro-6- (5-hydroxymethyl-tetrahydro-furan-3-yl) -benzene-1,3-diol
20 : cis-4-Fluoro-6-(5-hydroxyméthyl-tétrahydro-furan-3-yl)-benzène-1 ,3-diol  20: cis-4-Fluoro-6- (5-hydroxymethyl-tetrahydro-furan-3-yl) -benzene-1,3-diol
21 : trans-4-Fluoro-6-(2-hydroxyméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol 22 : cis-4-Fluoro-6-(2-hydroxyméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol21: trans-4-Fluoro-6- (2-hydroxymethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol 22: cis-4-Fluoro-6- (2-hydroxymethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
23 : cis-4-(8-Oxa-bicyclo[3.2.1 ]oct-3-yl)-benzène-1 ,3-diol 23: cis-4- (8-Oxa-bicyclo [3.2.1] oct-3-yl) -benzene-1,3-diol
24 : trans-4-(8-Oxa-bicyclo[3.2.1 ]oct-3-yl)-benzène-1 ,3-diol  24: trans-4- (8-Oxa-bicyclo [3.2.1] oct-3-yl) -benzene-1,3-diol
25 : 4-Fluoro-6-(tétrahydro-thiopyran-4-yl)-benzène-1 ,3-diol  25: 4-Fluoro-6- (tetrahydro-thiopyran-4-yl) -benzene-1,3-diol
Ces composés peuvent être préparés selon les modes opératoires décrits dans la demande WO2010063773. These compounds can be prepared according to the procedures described in the application WO2010063773.
Le composél : 4-(tétrahydro-pyran-4-yl)-benzène-1 ,3-diol est particulièrement préféré. The compound 4- (tetrahydro-pyran-4-yl) -benzene-1,3-diol is particularly preferred.
Figure imgf000007_0001
composé 1
Figure imgf000007_0001
compound 1
Le composé de formule (I) peut être présent dans la composition selon l'invention, en une teneur allant de 0,001 % à 10 % en poids, par rapport au poids total de la composition, plus particulièrement en une teneur allant de 0,05 % à 5 % en poids, et de préférence allant de 0,1 % à 2 % en poids, et préférentiellement allant de 0,2 % à 1 ,5 % en poids. The compound of formula (I) may be present in the composition according to the invention, in a content ranging from 0.001% to 10% by weight, relative to the total weight of the composition, more particularly in a content ranging from 0.05 % to 5% by weight, and preferably ranging from 0.1% to 2% by weight, and preferably ranging from 0.2% to 1.5% by weight.
La composition selon l'invention comprend au moins un polymère non ionique ou anionique. The composition according to the invention comprises at least one nonionic or anionic polymer.
Le ou les polymères non ioniques ou anioniques selon l'invention sont notamment choisis parmi :  The nonionic or anionic polymer or polymers according to the invention are especially chosen from:
- les homo- et copolymères de vinylpyrrolidone,  homopolymers and copolymers of vinylpyrrolidone,
- les alcools polyvinyliques,  polyvinyl alcohols,
- les celluloses, de préférence les hydroxyalkyl (C1 -C4) celluloses et les hydroxyalkyl (C1 - C4) alkyl (C1 -C4) celluloses,  celluloses, preferably hydroxyalkyl (C 1 -C 4) celluloses and hydroxyalkyl (C 1 -C 4) alkyl (C 1 -C 4) celluloses,
- les homo- et copolymères d'au moins un monomère à groupement sulfonique (polymères à groupements sulfoniques),  homopolymers and copolymers of at least one monomer containing a sulphonic group (polymers containing sulphonic groups),
- et leur mélanges.  - and their mixtures.
Parmi les homopolymères on peut citer les polyvinylpyrrolidones (PVP) de différents poids moléculaires, la masse moléculaire moyenne en poids dudit homopolymère étant mesurée par diffraction de la lumière. Among the homopolymers that may be mentioned polyvinylpyrrolidones (PVP) of different molecular weights, the weight average molecular weight of said homopolymer being measured by diffraction of light.
Plus particulièrement les polyvinylpyrrolidones (PVP) sont choisis parmi les polyvinylpyrrolidones ayant une masse moléculaire moyenne en poids allant de 2000 Daltons à 3000000 Daltons, plus particulièrement ayant une masse moléculaire moyenne en poids allant de 30000 Daltons à 2000000 Daltons, de préférence ayant une masse moléculaire moyenne en poids allant 40000 Daltons à 1500000 Daltons. Dans un mode de réalisation préféré de l'invention, le(s)dit homo- et copolymère(s) de vinylpyrrolidone présent dans la composition est choisi parmi le polyvinyipyrrolidone ayant une masse moléculaire moyenne en poids allant de 40000 Daltons à 80000 Daltons, et le polyvinyipyrrolidone ayant une masse moléculaire moyenne en poids allant de 900000 Daltons à 1500000 Daltons. More particularly, the polyvinylpyrrolidones (PVP) are chosen from polyvinylpyrrolidones having a weight average molecular weight ranging from 2000 Daltons to 3000000 Daltons, more particularly having a weight average molecular weight ranging from 30000 Daltons to 2000000 Daltons, preferably having a molecular weight. average in weight ranging from 40000 Daltons to 1500000 Daltons. In a preferred embodiment of the invention, said homopolymer (s) and copolymer (s) of vinylpyrrolidone present in the composition is chosen from polyvinylpyrrolidone having a weight average molecular weight ranging from 40000 Daltons to 80000 Daltons, and polyvinylpyrrolidone having a weight average molecular weight of from 900000 Daltons to 1500000 Daltons.
A titre d'exemple un polyvinyipyrrolidone conforme à l'invention est disponible sous la dénomination commerciale PVP K 30L® de la société ISP. By way of example, a polyvinylpyrrolidone according to the invention is available under the trade name PVP K 30L® from the company ISP.
A titre d'exemple un polyvinyipyrrolidone conforme à l'invention est disponible sous la dénomination commerciale PVP K 90® de la société de ISP (ASHLAND. By way of example, a polyvinylpyrrolidone according to the invention is available under the trade name PVP K 90® from the ISP company (ASHLAND.
Dans la composition de l'invention, on peut utiliser tout type de copolymère de vinylpyrrolidone. On entend ici par copolymère aussi bien des polymères résultant de la polymérisation de la vinylpyrrolidone avec une seule sorte de monomère que ceux résultant de la polymérisation de la vinylpyrrolidone avec plusieurs sortes de monomères, et par exemple avec deux sortes de monomères conduisant à l'obtention de terpolymère. In the composition of the invention, any type of vinylpyrrolidone copolymer can be used. The term "copolymer" as used herein refers to polymers resulting from the polymerization of vinylpyrrolidone with a single type of monomer, as those resulting from the polymerization of vinylpyrrolidone with several kinds of monomers, and for example with two kinds of monomers leading to the production of of terpolymer.
Parmi les copolymères on peut citer les copolymères polyvinylpyrrolidone/acétate de vinyle (PVPA A), polyvinylpyrrolidone/butène ; polyvinylpyrrolidone/décène, polyvinylpyrrolidone/hexadécène, polyvinylpyrrolidone/acide(méth)acrylique/méthacrylate d'alkyle en C8-C20 notamment lauryle, polyvinylpyrrolidone/acétate de vinyle/ acide itaconique, polyvinylpyrrolidone/acétate de vinyle/propionate de vinyle. Among the copolymers, mention may be made of polyvinylpyrrolidone / vinyl acetate copolymers (PVPA A), polyvinylpyrrolidone / butene copolymers; polyvinylpyrrolidone / decene, polyvinylpyrrolidone / hexadecene, polyvinylpyrrolidone / (meth) acrylic acid / C8-C20 alkyl methacrylate including lauryl, polyvinylpyrrolidone / vinyl acetate / itaconic acid, polyvinylpyrrolidone / vinyl acetate / vinyl propionate.
Dans un mode de réalisation particulier selon l'invention, les homo- et copolymères sont choisis parmi les polyvinylpyrrolidones (PVP) et les copolymères vinylpyrrolidone/acétate de vinyle (PVPA/A). In a particular embodiment according to the invention, the homo- and copolymers are chosen from polyvinylpyrrolidones (PVP) and vinylpyrrolidone / vinyl acetate copolymers (PVPA / A).
Ces copolymères sont disponibles dans le commerce, par exemple sous la marque LUVISKOL® (PVP et PVPA/A) auprès de la société BASF et sous les dénominations PVP-K ou PVPA/A auprès de la société ISP.  These copolymers are commercially available, for example under the trademark LUVISKOL® (PVP and PVPA / A) from BASF and under the names PVP-K or PVPA / A from ISP.
Les alcools polyvinyliques (PVA) sont notamment choisis parmi les PVA ayant une masse moléculaire moyenne en poids allant de 10 000 Daltons à 200000 Daltons, plus particulièrement ayant une masse moléculaire moyenne en poids allant de 100 000 Daltons à 200 000 Daltons. The polyvinyl alcohols (PVA) are chosen in particular from PVA having a weight average molecular weight ranging from 10,000 Daltons to 200,000 Daltons, more particularly having a weight average molecular weight ranging from 100,000 Daltons to 200,000 Daltons.
Les alcools polyvinyliques selon l'invention peuvent des polymères de différents degrés d'hydrolyse et/ou de différentes viscosités. On peut utiliser en particulier l'alcool polyvinylique ayant un degré d'hydrolyse variant de 74 à 99 % et/ou ayant une viscosité allant de 2,6 à 67 cps (2,6 à 67 mPa.s). Comme alcool polyvinylique, on peut citer par exemple le produit disponible sous la dénomination commerciale CELVOL 205 PV ALCOHOL® de la société Sekisui Speciality Chemicals. The polyvinyl alcohols according to the invention can have polymers of different degrees of hydrolysis and / or different viscosities. In particular, polyvinyl alcohol having a degree of hydrolysis varying from 74 to 99% and / or having a viscosity ranging from 2.6 to 67 cps (2.6 to 67 mPa.s) can be used. As polyvinyl alcohol, mention may be made for example the product available under the trade name CELVOL 205 PV ALCOHOL® from Sekisui Specialty Chemicals.
Les celluloses pouvant être utilisées selon l'invention sont par exemple choisies parmi The celluloses that can be used according to the invention are for example chosen from
- les hydroxypropyl méthylcelluloses notamment vendues sous les dénominations METHOCEL F4M STANDARD" ou METHOCEL K 15M par la Société DOW CHEMICAL;hydroxypropyl methylcelluloses sold especially under the names METHOCEL F4M STANDARD or METHOCEL K 15M by the company DOW CHEMICAL;
- les méthylcelluloses par exemple vendues sous la dénomination TYLOSE MH 200 KG4 par la Société CLARIANT; methylcelluloses, for example sold under the name TYLOSE MH 200 KG4 by CLARIANT;
- les hydroxyéthylcelluloses par exemple vendue sous la dénomination NATROSOL 250 HHR par la société ASHLAND the hydroxyethylcelluloses for example sold under the name NATROSOL 250 HHR by the company ASHLAND
- les hydroxypropylcelluloses par exemple vendue sous la dénomination "KLUCEL H" par la Société ASHLAND;  hydroxypropylcelluloses for example sold under the name "KLUCEL H" by the company ASHLAND;
- les hydroxyéthyl méthylcelluloses par exemple vendues sous la dénomination "TYLOSE MH 300" par la Société HOECHST  the hydroxyethyl methylcelluloses for example sold under the name "TYLOSE MH 300" by the company HOECHST
Selon l'invention, les polymères à groupements sulfoniques sont des homo ou copolymères susceptibles d'être obtenus à partir d'au moins un monomère à insaturation éthylénique et à groupement sulfonique, pouvant être sous forme libre ou partiellement ou totalement neutralisée. According to the invention, the polymers containing sulphonic groups are homo or copolymers that can be obtained from at least one ethylenically unsaturated monomer containing a sulphonic group, which can be in free form or partially or totally neutralized.
De façon préférentielle, les polymères conformes à l'invention peuvent être neutralisés partiellement ou totalement par une base minérale (soude, potasse, ammoniaque) ou une base organique telle que la mono-, di- ou tri-éthanolamine, un aminométhylpropanediol, la N-méthyl-glucamine, les acides aminés basiques comme l'arginine et la lysine, et les mélanges de ces composés. Ils sont généralement neutralisés. On entend dans la présente invention par « neutralisés », des polymères totalement ou pratiquement totalement neutralisés, c'est-à-dire neutralisés à au moins 90 %. Les polymères utilisés dans la composition de l'invention ont généralement un poids moléculaire moyen en nombre allant de 1000 à 20 000 000 g/mole, de préférence allant de 20 000 à 5 000 000 et plus préférentiellement encore de 100 000 à 1 500 000 g/mole. Preferably, the polymers in accordance with the invention may be partially or completely neutralized with a mineral base (sodium hydroxide, potassium hydroxide, aqueous ammonia) or an organic base such as mono-, di- or tri-ethanolamine, aminomethylpropanediol, N methyl glucamine, basic amino acids such as arginine and lysine, and mixtures of these compounds. They are usually neutralized. The term "neutralized" in the present invention means polymers that are totally or substantially completely neutralized, that is to say neutralized to at least 90%. The polymers used in the composition of the invention generally have a number-average molecular weight ranging from 1000 to 20,000,000 g / mol, preferably from 20,000 to 5,000,000 and even more preferably from 100,000 to 1,500,000. g / mol.
Ces polymères selon l'invention peuvent être réticulés ou non réticulés. These polymers according to the invention may be crosslinked or non-crosslinked.
Les monomères à groupements sulfoniques du polymère utilisé dans la composition de l'invention sont choisis notamment parmi l'acide vinylsulfonique, l'acide styrènesulfonique, les acides (méth)acrylamido-(Ci-C22)alkylsulfoniques, les acides N-(d-C22)alkyl- (méth)acrylamido-(Ci-C22)-alkylsulfoniques comme l'acide undécyl-acrylamido-méthane- sulfonique, ainsi que leurs formes partiellement ou totalement neutralisées, et leurs mélanges. The monomers containing sulphonic groups of the polymer used in the composition of the invention are chosen in particular from vinylsulphonic acid, styrenesulphonic acid, (meth) acrylamido (C 1 -C 22 ) alkylsulphonic acids, N- (dC) acids. 22 ) alkyl- (meth) acrylamido (C 1 -C 22 ) alkylsulfonic acid such as undecyl-acrylamido-methane- sulfonic acid, as well as their partially or totally neutralized forms, and their mixtures.
Selon un mode préféré de réalisation de l'invention, les monomères à groupement sulfonique sont choisis parmi les acides (méth)acrylamido(Ci-C22)alkylsulfoniques tels que par exemple l'acide acrylamido-méthane-sulfonique, l'acide acrylamido-éthane-sulfonique, l'acide acrylamido-propane-sulfonique, l'acide 2-acrylamido-2-méthylpropane-sulfonique, l'acide 2-méthacrylamido-2-méthylpropane-sulfonique, l'acide 2-acrylamido-n-butane- sulfonique, l'acide 2-acrylamido-2,4,4-triméthylpentane-sulfonique, l'acide 2- méthacrylamido-dodécyl-sulfonique, l'acide 2-acrylamido-2,6-diméthyl-3-heptane- sulfonique, ainsi que leurs formes partiellement ou totalement neutralisées, et leurs mélanges. According to a preferred embodiment of the invention, the monomers containing a sulphonic group are chosen from (meth) acrylamido (Ci-C 2 2) alkylsulphonic acids, such as, for example, acrylamido-methanesulfonic acid and acrylamido acid. ethanesulfonic acid, acrylamido-propanesulfonic acid, 2-acrylamido-2-methylpropanesulfonic acid, 2-methacrylamido-2-methylpropanesulfonic acid, 2-acrylamido-n-butane sulfonic acid, 2-acrylamido-2,4,4-trimethylpentanesulfonic acid, 2-methacrylamido-dodecylsulphonic acid, 2-acrylamido-2,6-dimethyl-3-heptanesulfonic acid, as well as their partially or completely neutralized forms, and their mixtures.
Plus particulièrement, on utilise l'acide 2-acrylamido-2-méthylpropane-sulfonique (AMPS) ainsi que ses formes partiellement ou totalement neutralisées. More particularly, 2-acrylamido-2-methylpropanesulfonic acid (AMPS) and its partially or completely neutralized forms are used.
Lorsque les polymères sont réticulés, les agents de réticulation peuvent être choisis parmi les composés à polyinsaturation oléfinique couramment utilisés pour la réticulation des polymères obtenus par polymérisation radicalaire. When the polymers are crosslinked, the crosslinking agents may be chosen from the olefinically-polyunsaturated compounds commonly used for crosslinking the polymers obtained by radical polymerization.
Selon un mode préféré de réalisation de l'invention, l'agent de réticulation est choisi parmi le méthylène-bis-acrylamide, le méthacrylate d'allyle ou le triméthylol propane triacrylate (TMPTA). Le taux de réticulation va en général de 0,01 à 10 % en mole et plus particulièrement de 0,2 à 2 % en mole par rapport au polymère. According to a preferred embodiment of the invention, the crosslinking agent is chosen from methylene-bis-acrylamide, allyl methacrylate or trimethylol propane triacrylate (TMPTA). The degree of crosslinking generally ranges from 0.01 to 10 mol% and more particularly from 0.2 to 2 mol% relative to the polymer.
L'homopolymère de monomères à groupements sulfoniques peut être réticulé avec un ou plusieurs agents de réticulation. The homopolymer of monomers containing sulfonic groups may be crosslinked with one or more crosslinking agents.
Ces homopolymères sont généralement réticulés et neutralisés. These homopolymers are generally crosslinked and neutralized.
Comme polymères à groupements sulfoniques, on peut citer notamment l'homopolymère réticulé et neutralisé d'acide 2-acrylamido 2-méthylpropane sulfonique, commercialisé par la société Clariant sous la dénomination commerciale « Hostacerin® AMPS » (nom CTFA : ammonium polyacryldiméthyltauramide). As polymers with sulfonic groups, mention may be made in particular of the crosslinked and neutralized homopolymer of 2-acrylamido-2-methylpropanesulphonic acid, marketed by the company Clariant under the trademark "Hostacerin® AMPS" (CTFA name: ammonium polyacryldimethyltauramide).
Le (ou les) polymères non ioniques ou anioniques peut (peuvent) être présent(s) à une teneur allant de 0,01 % à 15 % en poids, de préférence allant de 0,1 % à 1 0 % en poids, par rapport au poids total de la composition. Selon un mode particulier, les celluloses et les polymères de monomères à groupement sulfonique peuve(nt) être présent(s) à une teneur allant de 0,01 % à 5 % en poids, de préférence allant de 0,1 % à 2 % en poids, mieux allant de 0,2 % à 1 % en poids, par rapport au poids total de la composition. The nonionic or anionic polymer (s) may be present at a content ranging from 0.01% to 15% by weight, preferably ranging from 0.1% to 10% by weight, relative to the total weight of the composition. According to a particular embodiment, the celluloses and the polymers of monomers containing a sulfonic group may be present in a content ranging from 0.01% to 5% by weight, preferably ranging from 0.1% to 2%. by weight, more preferably from 0.2% to 1% by weight, relative to the total weight of the composition.
De manière particulièrement avantageuse, le (ou les) polymères PVP et alcools polyvinylique peuve(nt) être présent(s) à une teneur allant de 0,1 % à 10 % en poids, de préférence allant de 1 % à 5 % en poids, par rapport au poids total de la composition. Selon un mode de réalisation préféré, le rapport massique du (des)dit polymère /composé de formule (I) présents dans la composition selon l'invention est de préférence de 0,1 à 15, par exemple allant de 1 à 10. Particularly advantageously, the PVP polymer (s) and polyvinyl alcohol (s) can be present in a content ranging from 0.1% to 10% by weight, preferably ranging from 1% to 5% by weight. , relative to the total weight of the composition. According to a preferred embodiment, the mass ratio of the said polymer / compound of formula (I) present in the composition according to the invention is preferably from 0.1 to 15, for example ranging from 1 to 10.
La composition selon la présente invention comprend au moins un glycol. The composition according to the present invention comprises at least one glycol.
Par glycol selon l'invention on entend une chaîne hydrocarbonée comportant au moins 2 atomes de carbone, de préférence de 2 à 50 atomes de carbones, de préférence de 2 à 20 atomes de carbones, de préférence ayant de 2 à 10 atomes de carbone, et préférentiellement ayant de 2 à 6 atomes de carbones, et portant deux groupes hydroxyle. Les glycols utilisés dans la présente invention peuvent présenter une masse moléculaire moyenne en poids inférieure ou égale à 1000, de préférence comprise entre 60 et 500. By glycol according to the invention is meant a hydrocarbon chain comprising at least 2 carbon atoms, preferably 2 to 50 carbon atoms, preferably 2 to 20 carbon atoms, preferably having 2 to 10 carbon atoms, and preferably having from 2 to 6 carbon atoms, and bearing two hydroxyl groups. The glycols used in the present invention may have a weight average molecular weight less than or equal to 1000, preferably between 60 and 500.
Le glycol peut être un glycol naturel ou synthétique. Le glycol peut avoir une structure linéaire, ramifiée ou cyclique. The glycol may be a natural or synthetic glycol. The glycol may have a linear, branched or cyclic structure.
Le glycol peut être choisi parmi le diéthylèneglycol, le propylène glycol, le dipropylène glycol, le butylène glycol, le pentylène glycol, l'hexylène glycol, le 1 ,3-propanediol, le 1 ,5- pentanediol, les polyéthylèneglycols, notamment ayant de 5 à 50 groupes d'oxyde d'éthylène, et leurs mélanges. The glycol may be chosen from diethylene glycol, propylene glycol, dipropylene glycol, butylene glycol, pentylene glycol, hexylene glycol, 1,3-propanediol, 1,5-pentanediol and polyethylene glycols, especially having 5 to 50 ethylene oxide groups, and mixtures thereof.
Plus particulièrement le glycol peut-être choisi dans le groupe constitué du dipropylène glycol, du propylène glycol, du propanediol-1 ,3, du butylène glycol, et leur mélange, et plus particulièrement le dipropylène glycol. Le(s)dit glycol(s) peut(vent) être présent(s) en une teneur allant de 0,50 % à 50 % en poids, par rapport au poids total de la composition, de préférence allant de 3 % à 30 % en poids, et préférentiellement allant de 5 % à 20 % en poids, par rapport au poids total de la composition. Selon l'invention, la composition selon la présente invention comprend de l'eau. More particularly, the glycol may be chosen from the group consisting of dipropylene glycol, propylene glycol, propanediol-1, 3, butylene glycol, and their mixture, and more particularly dipropylene glycol. The said glycol (s) may be present in a content ranging from 0.50% to 50% by weight, relative to the total weight of the composition, preferably ranging from 3% to 30% by weight. % by weight, and preferably ranging from 5% to 20% by weight, relative to the total weight of the composition. According to the invention, the composition according to the present invention comprises water.
La quantité d'eau n'est pas limitée, et peut aller de 50 % à 99 % en poids, de préférence de 55 % à 95 % en poids, et plus préférablement de 70 % à 90 % en poids, par rapport au poids total de la composition. The amount of water is not limited, and may range from 50% to 99% by weight, preferably from 55% to 95% by weight, and more preferably from 70% to 90% by weight, based on weight. total of the composition.
Selon un mode particulier de l'invention, la composition selon la présente invention comprend en outre au moins un monoalcool en C2-C4. According to a particular embodiment of the invention, the composition according to the present invention further comprises at least one C2-C4 monoalcohol.
Les monoalcools en C2-C4 comprennent un groupe hydroxy et de 2 à 4 atomes de carbone. On peut utiliser l'éthanol, le propanol, l'isopropanol, le butanol-1 , l'isobutanol et leurs mélanges. Le monoalcool en C2-C4 est de préférence l'éthanol.  C2-C4 monoalcohols comprise a hydroxy group and 2 to 4 carbon atoms. Ethanol, propanol, isopropanol, butanol-1, isobutanol and mixtures thereof can be used. The C2-C4 monoalcohol is preferably ethanol.
La concentration en monoalcool en C2-C4 peut aller de 0,1 % à 30 % en poids, de préférence de 0,5 % à 15 % en poids, par rapport au poids total de la composition. The concentration of C2-C4 monoalcohol can range from 0.1% to 30% by weight, preferably from 0.5% to 15% by weight, relative to the total weight of the composition.
Les compositions utilisées selon l'invention peuvent comprendre un milieu physiologiquement acceptable, c'est-à-dire un milieu convenant à l'administration d'une composition par voie topique, soit c'est-à-dire compatible avec les matières kératiniques d'êtres humains telles que la peau, le cuir chevelu, les cheveux, les ongles. The compositions used according to the invention may comprise a physiologically acceptable medium, that is to say a medium which is suitable for the topical administration of a composition, that is to say compatible with the keratinous substances of the present invention. human beings such as the skin, the scalp, the hair, the nails.
Selon l'invention un milieu physiologiquement acceptable est préférentiellement un milieu cosmétiquement acceptable, c'est-à-dire sans odeur, ou aspect désagréable, et qui est parfaitement compatible avec la voie d'administration topique. Par matières kératiniques selon l'invention on entend la peau, du corps, visage et/ou contour des yeux, les lèvres, les ongles, les muqueuses, les cils, les sourcils, les poils, le cuir chevelu et/ou les cheveux, ou toute autre zone cutanée du corps. Plus particulièrement les matières kératiniques selon l'invention sont le cuir chevelu, les cheveux, et/ou la peau. According to the invention a physiologically acceptable medium is preferably a cosmetically acceptable medium, that is to say without odor, or unpleasant appearance, and which is perfectly compatible with the topical route of administration. The term "keratin materials" according to the invention is understood to mean the skin, the body, the face and / or the contour of the eyes, the lips, the nails, the mucous membranes, the eyelashes, the eyebrows, the hairs, the scalp and / or the hair, or any other skin area of the body. More particularly, the keratin materials according to the invention are the scalp, the hair, and / or the skin.
De préférence les matières kératiniques selon l'invention sont le cuir chevelu et/ou les cheveux. Preferably, the keratin materials according to the invention are the scalp and / or the hair.
De préférence les matières kératiniques selon l'invention est la peau.  Preferably the keratin materials according to the invention is the skin.
Par « la peau», on entend l'ensemble de la peau du corps, et de manière préférée, la peau du visage, du décolleté, du cou, des bras et avant-bras, voire de manière plus préférée encore, la peau du visage, notamment du front, nez, joues, menton, contour des yeux. By "skin" is meant all of the skin of the body, and preferably, the skin of the face, décolleté, neck, arms and forearms, or even more preferably, the skin of the skin. face, including forehead, nose, cheeks, chin, eye area.
Comme précisé ci-après, le composé de formule (I) est avantageusement présent, dans les compositions conformes à l'invention, sous une forme solubilisée. A titre d'exemple la composition selon l'invention peut-être destinée à être administrée par voie topique, c'est à dire par application en surface de la matière kératinique considérée, telle que la peau considérée. La composition de l'invention peut être une composition cosmétique (soit destinée à un usage cosmétique) ou dermatologique. Préférentiellement selon l'invention, la composition est une composition cosmétique et encore plus préférentiellement une composition cosmétique d'application topique. As specified below, the compound of formula (I) is advantageously present in the compositions according to the invention in a solubilized form. By way of example, the composition according to the invention may be intended to be administered topically, that is to say by surface application of the keratin material in question, such as the skin under consideration. The composition of the invention may be a cosmetic composition (either intended for cosmetic use) or dermatological. Preferably, according to the invention, the composition is a cosmetic composition and even more preferentially a cosmetic composition for topical application.
On entend notamment par « composition cosmétique » une substance ou une préparation destinée à être mise en contact avec les diverses parties superficielles du corps humain, notamment l'épiderme, les systèmes pileux et capillaire, les ongles, les lèvres, les muqueuses buccales, en vue, exclusivement ou principalement, de les nettoyer, de les embellir, de les parfumer, d'en modifier l'aspect, de les protéger, de les maintenir en bon état ou de corriger les odeurs corporelles.  The term "cosmetic composition" is understood to mean a substance or a preparation intended to be brought into contact with the various superficial parts of the human body, in particular the epidermis, the hair and hair systems, the nails, the lips and the oral mucosa, in particular view, exclusively or mainly, to clean, embellish, perfume, change the appearance, protect, maintain or repair body odors.
Les compositions selon l'invention peuvent se présenter sous forme de solutions aqueuses, de solutions hydroalcooliques, d'émulsions huile-dans-eau (H/E) ou eau-dans- huile (E/H) ou multiple (triple : E/H/E ou H/E/H), de gels aqueux. Ces compositions sont préparées selon les méthodes usuelles. The compositions according to the invention may be in the form of aqueous solutions, hydroalcoholic solutions, oil-in-water (O / W) or water-in-oil (W / O) or multiple (triple: E / W) emulsions. H / E or H / E / H), aqueous gels. These compositions are prepared according to the usual methods.
La composition peut comprendre au moins une huile. Comme huiles utilisables, on peut citer par exemple : The composition may comprise at least one oil. As usable oils, there may be mentioned for example:
- les huiles hydrocarbonées d'origine végétale, telles que les triglycérides liquides d'acides gras comportant de 4 à 10 atomes de carbone comme les triglycérides des acides heptanoïque ou octanoïque ou encore, par exemple les huiles de tournesol, de maïs, de soja, de courge, de pépins de raisin, de sésame, de noisette, d'abricot, de macadamia, d'arara, de ricin, d'avocat, les triglycérides des acides caprylique/caprique comme ceux vendus par la société Stearineries Dubois ou ceux vendus sous les dénominations « Miglyol 810 », « 812 » et « 818 » par la société Dynamit Nobel, l'huile de jojoba, l'huile de beurre de karité;  hydrocarbon-based oils of vegetable origin, such as liquid triglycerides of fatty acids containing from 4 to 10 carbon atoms, for instance triglycerides of heptanoic or octanoic acids or, for example, sunflower, corn or soybean oils, squash, grape seed, sesame, hazelnut, apricot, macadamia, arara, castor oil, avocado, triglycerides of caprylic / capric acids such as those sold by Stearineries Dubois or those sold under the names "Miglyol 810", "812" and "818" by Dynamit Nobel, jojoba oil, shea butter oil;
- les esters et les éthers de synthèse, notamment d'acides gras, comme les huiles de formules R1 COOR2 et R10R2 dans laquelle R1 représente le reste d'un acide gras comportant de 8 à 29 atomes de carbone, et R2 représente une chaîne hydrocarbonée, ramifiée ou non, contenant de 3 à 30 atomes de carbone, comme par exemple l'huile de Purcellin, l'isononanoate d'isononyle, le myristate d'isopropyle, le palmitate d'éthyl-2- hexyle, le stéarate d'octyl-2-dodécyle, l'érucate d'octyl-2-dodécyle, l'isostéarate d'isostéaryle ; les esters hydroxylés comme l'isostéaryl lactate, l'octylhydroxystéarate, l'hydroxystéarate d'octyldodécyle, le diisostéaryl-malate, le citrate de triisocétyle ; les heptanoates, octanoates, décanoates d'alcools gras ; les esters de polyol, comme le dioctanoate de propylène glycol, le diheptanoate de néopentylglycol et le diisononanoate de diéthylèneglycol ; et les esters du pentaérythritol comme le tétraisostéarate de pentaérythrityle ; esters and synthetic ethers, in particular of fatty acids, such as the oils of formulas R 1 COOR 2 and R 10 R 2 in which R 1 represents the residue of a fatty acid comprising from 8 to 29 carbon atoms, and R 2 represents a hydrocarbon-based chain , branched or unbranched, containing from 3 to 30 carbon atoms, for example purcellin oil, isononyl isononanoate, isopropyl myristate, 2-ethylhexyl palmitate, stearate of octyl-2-dodecyl, octyl-2-dodecyl erucate, isostearyl isostearate; hydroxylated esters such as isostearyl lactate, octyl hydroxystearate, octyldodecyl hydroxystearate, diisostearyl malate, triisocetyl citrate; heptanoates, octanoates, decanoates of fatty alcohols; polyol esters, such as propylene glycol dioctanoate, neopentyl glycol diheptanoate and diethylene glycol diisononanoate; and pentaerythritol esters such as pentaerythrityl tetraisostearate;
- les hydrocarbures linéaires ou ramifiés, d'origine minérale ou synthétique, tels que les huiles de paraffine, volatiles ou non, et leurs dérivés, la vaseline, les polydécènes, le polyisobutène hydrogéné tel que l'huile de parléam ;  linear or branched hydrocarbons of mineral or synthetic origin, such as paraffin oils, volatile or not, and their derivatives, petroleum jelly, polydecenes, hydrogenated polyisobutene such as parleam oil;
- les alcools gras ayant de 8 à 26 atomes de carbone, comme l'alcool cétylique, l'alcool stéarylique et leur mélange (alcool cétylstéarylique), l'octyldodécanol, le 2-butyloctanol, le 2-hexyldécanol, le 2-undécylpentadécanol, l'alcool oléique ou l'alcool linoléique ;  fatty alcohols having from 8 to 26 carbon atoms, such as cetyl alcohol, stearyl alcohol and their mixture (cetylstearyl alcohol), octyldodecanol, 2-butyloctanol, 2-hexyldecanol, 2-undecylpentadecanol, oleic alcohol or linoleic alcohol;
- les huiles de silicone comme les polyméthylsiloxanes (PDMS) volatiles ou non à chaîne siliconée linéaire ou cyclique, liquides ou pâteux à température ambiante, notamment les cyclopolydiméthylsiloxanes (cyclométhicones) telles que la cyclohexasiloxane ; les polydiméthylsiloxanes comportant des groupements alkyle, alcoxy ou phényle, pendant ou en bout de chaîne siliconée, groupements ayant de 2 à 24 atomes de carbone ; les silicones phénylées comme les phényltriméthicones, les phényldiméthicones, les phényltriméthylsiloxydiphényl-siloxanes, les diphényl-diméthicones, les diphénylméthyldiphényl trisiloxanes, les 2-phényléthyltriméthyl-siloxysilicates, et les polyméthylphénylsiloxanes ; silicone oils such as volatile or non-volatile polymethylsiloxanes (PDMS) with a linear or cyclic silicone chain, which are liquid or pasty at room temperature, in particular cyclopolydimethylsiloxanes (cyclomethicones) such as cyclohexasiloxane; polydimethylsiloxanes comprising alkyl, alkoxy or phenyl groups, during or at the end of the silicone chain, groups having from 2 to 24 carbon atoms; phenyl silicones such as phenyltrimethicones, phenyldimethicones, phenyltrimethylsiloxydiphenylsiloxanes, diphenyl-dimethicones, diphenylmethyldiphenyltrisiloxanes, 2-phenylethyltrimethylsiloxysilicates, and polymethylphenylsiloxanes;
- leurs mélanges.  - their mixtures.
On entend par « huile hydrocarbonée » dans la liste des huiles citées ci-dessus, toute huile comportant majoritairement des atomes de carbone et d'hydrogène, et éventuellement des groupements ester, éther, fluoré, acide carboxylique et/ou alcool. La composition selon l'invention peut comprendre des corps solides à la température ambiante (25 °C) comme par exemple les acides gras comportant de 8 à 30 atomes de carbone, comme l'acide stéarique, l'acide laurique, l'acide palmitique et l'acide oléique ; les cires comme la lanoline, la cire d'abeille, la cire de Carnauba ou de Candellila, les cires de paraffine, les cires microcristallines, la cérésine ou l'ozokérite, les cires synthétiques comme les cires de polyéthylène, les cires de Fischer-Tropsch. The term "hydrocarbon-based oil" in the list of oils mentioned above, any oil predominantly comprising carbon and hydrogen atoms, and optionally ester, ether, fluoro, carboxylic acid and / or alcohol groups. The composition according to the invention may comprise solid bodies at ambient temperature (25 ° C.), for example fatty acids containing from 8 to 30 carbon atoms, such as stearic acid, lauric acid and palmitic acid. and oleic acid; waxes such as lanolin, beeswax, carnauba or candelilla wax, paraffin waxes, microcrystalline waxes, ceresin or ozokerite, synthetic waxes such as polyethylene waxes, Fischer waxes, Tropsch.
Ces corps gras peuvent être choisis de manière variée par l'homme du métier afin de préparer une composition ayant les propriétés, par exemple de consistance ou de textures, souhaitées. Selon un mode particulier de réalisation de l'invention, la composition selon l'invention est une émulsion eau-dans-huile (E/H) ou huile-dans-eau (H/E). La proportion de la phase huileuse de l'émulsion peut aller de 1 % à 80 % en poids, et de préférence de 5 % à 50 % en poids par rapport au poids total de la composition. Les émulsions contiennent généralement au moins un émulsionnant, notamment choisi parmi les émulsionnants amphotères, anioniques, cationiques ou non ioniques, utilisés seuls ou en mélange, et éventuellement un co-émulsionnant. Les émulsionnants sont choisis de manière appropriée suivant l'émulsion à obtenir (E/H ou H/E). L'émulsionnant et le co-émulsionnant sont généralement présents dans la composition, en une proportion allant de 0,3 à 30 % en poids, et de préférence de 0,5 à 20 % en poids par rapport au poids total de la composition. These fatty substances may be chosen in a varied manner by those skilled in the art in order to prepare a composition having the desired properties, for example of consistency or textures. According to a particular embodiment of the invention, the composition according to the invention is a water-in-oil (W / O) or oil-in-water (O / W) emulsion. The proportion of the oily phase of the emulsion may range from 1% to 80% by weight, and preferably from 5% to 50% by weight relative to the total weight of the composition. The emulsions generally contain at least one emulsifier, especially chosen from amphoteric, anionic, cationic or nonionic emulsifiers, used alone or as a mixture, and optionally a co-emulsifier. The emulsifiers are suitably selected according to the emulsion to be obtained (W / O or O / W). The emulsifier and the co-emulsifier are generally present in the composition, in a proportion ranging from 0.3 to 30% by weight, and preferably from 0.5 to 20% by weight relative to the total weight of the composition.
Pour les émulsions E/H, on peut citer par exemple comme émulsionnants les dimethicone copolyols tels que le mélange de cyclomethicone et de dimethicone copolyol, vendu sous la dénomination « DC 5225 C » par la société Dow Corning, et les alkyl-dimethicone copolyols tels que le Laurylmethicone copolyol vendu sous la dénomination « Dow Corning 5200 Formulation Aid » par la société Dow Corning et le Cetyl dimethicone copolyol vendu sous la dénomination « Abil EM 90® » par la société Goldschmidt. For the W / O emulsions, examples of emulsifiers that may be mentioned include dimethicone copolyols such as the mixture of cyclomethicone and dimethicone copolyol, sold under the name "DC 5225 C" by the company Dow Corning, and the alkyl-dimethicone copolyols such as Laurylmethicone copolyol sold under the name "Dow Corning 5200 Formulation Aid" by the company Dow Corning and Cetyl dimethicone copolyol sold under the name "Abil EM 90®" by the company Goldschmidt.
Pour les émulsions H/E, on peut citer par exemple comme émulsionnants, les émulsionnants non ioniques tels que les esters d'acides gras et de glycérol oxyalkylénés (plus particulièrement polyoxyéthylénés) ; les esters d'acides gras et de sorbitan oxyalkylénés ; les esters d'acides gras oxyalkylénés (oxyéthylénés et/ou oxypropylénés) ; les éthers d'alcools gras oxyalkylénés (oxyéthylénés et/ou oxypropylénés) ; les esters de sucres comme le stéarate de sucrose ; et leurs mélanges tels que le mélange de stéarate de glycéryle et de stéarate de PEG-100. For O / W emulsions, mention may be made, for example, as emulsifiers, of nonionic emulsifiers such as oxyalkylenated (more particularly polyoxyethylenated) fatty acid esters of glycerol; oxyalkylenated fatty acid and sorbitan esters; oxyalkylenated fatty acid esters (oxyethylenated and / or oxypropylenated); oxyalkylenated fatty alcohol ethers (oxyethylenated and / or oxypropylenated); sugar esters such as sucrose stearate; and mixtures thereof such as the mixture of glyceryl stearate and PEG-100 stearate.
La composition peut être un gel aqueux, et notamment comprendre des gélifiants aqueux usuels. The composition may be an aqueous gel, and in particular comprise conventional aqueous gelling agents.
De façon connue, la composition selon l'invention peut contenir également des adjuvants habituels dans le domaine cosmétique ou dermatologique tels que les gélifiants, les épaississants les polymères filmogènes, les conservateurs, les parfums, les charges, les filtres UV, les bactéricides, les absorbeurs d'odeur, les matières colorantes, les extraits végétaux, les vitamines, les polyols tels que la glycérine, les sucres tels que le sorbitol, les actifs cosmétiques et dermatologiques, et les sels. Les quantités de ces différents adjuvants sont celles classiquement utilisées dans le domaine considéré, et par exemple de 0,001 à 20 % du poids total de la composition. In a known manner, the composition according to the invention may also contain adjuvants which are customary in the cosmetic or dermatological field, such as gelling agents, thickeners, film-forming polymers, preservatives, perfumes, fillers, UV filters, bactericidal agents, odor absorbers, dyestuffs, plant extracts, vitamins, polyols such as glycerin, sugars such as sorbitol, cosmetic and dermatological active ingredients, and salts. The amounts of these various adjuvants are those conventionally used in the field under consideration, and for example from 0.001 to 20% of the total weight of the composition.
La composition comprend de préférence de la glycérine. The composition preferably comprises glycerin.
Avantageusement, la composition selon l'invention a un pH allant de 3 à 7. De préférence, le pH de la composition va de 4 à 6. Plus particulièrement l'invention a encore pour objet un procédé de traitement cosmétique de soin, de maquillage, et/ou de nettoyage des matières kératiniques, notamment la peau, comprenant l'application sur sur lesdites matières kératiniques, notamment la peau, d'une composition selon l'invention telle que décrite précédemment. Advantageously, the composition according to the invention has a pH ranging from 3 to 7. Preferably, the pH of the composition ranges from 4 to 6. More particularly, the subject of the invention is also a process for the cosmetic treatment of skincare, makeup, and / or cleaning of keratinous substances, in particular the skin, comprising the application on said keratin materials, in particular the skin, of a composition according to the invention as described above.
Ledit procédé de traitement cosmétique de soin, de maquillage, et/ou de nettoyage de la peau est non thérapeutique.  Said method of cosmetic treatment of care, makeup, and / or cleansing of the skin is non-therapeutic.
L'invention a également pour objet un procédé cosmétique de dépigmentation, d'éclaircissement et/ou de blanchiment des matières kératiniques, notamment la peau humaine, les poils ou les cheveux comprenant l'application sur lesdites matières kératiniques d'une composition selon l'invention telle que décrite précédemment.  The subject of the invention is also a cosmetic process for the depigmentation, lightening and / or bleaching of keratin materials, in particular human skin, hair or hair, comprising the application to said keratin materials of a composition according to the invention. invention as described above.
L'invention a encore pour objet un procédé cosmétique de prévention et/ou de traitement des signes cutanés du vieillissement, comprenant au moins une étape d'application topique sur les matières kératiniques, telles que la peau, d'une composition selon l'invention telle que décrite précédemment. The subject of the invention is also a cosmetic process for preventing and / or treating cutaneous signs of aging, comprising at least one step of topical application to keratin materials, such as the skin, of a composition according to the invention as previously described.
Les signes cutanés du vieillissement à prévenir et/ou traiter dans le procédé cosmétique selon l'invention peuvent être choisis parmi les rides et ridules, et/ou de lutter contre la peau flétrie, molle et/ou amincie. L'invention a également pour objet l'utilisation cosmétique d'une composition selon l'invention telle que définie précédemment, pour le soin, le maquillage et/ou le nettoyage des matières kératiniques.  The cutaneous signs of the aging to be prevented and / or treated in the cosmetic process according to the invention may be chosen from the lines and wrinkles, and / or to fight against the skin withered, soft and / or thinned. The invention also relates to the cosmetic use of a composition according to the invention as defined above, for the care, makeup and / or cleaning of keratin materials.
Dans un autre mode de réalisation, l'invention concerne un procédé de traitement cosmétique de soin, de maquillage, et/ou de nettoyage des matières kératiniques, notamment la peau, comprenant l'administration, par voie topique, à un individu, d'une composition telle que définie précédemment. In another embodiment, the invention relates to a cosmetic treatment method for the care, makeup, and / or cleaning of keratinous substances, in particular the skin, comprising the administration, topically, to an individual, of a composition as defined above.
Les expressions « compris entre ... et ... » et « allant de ... à ... », ou « au moins.. », ou « au moins de.. » doivent se comprendre bornes incluses, sauf si le contraire est spécifié. The expressions "between ... and ..." and "from ... to ...", or "at least ..", or "at least .." must be understood as inclusive, unless the opposite is specified.
Les exemples ci-après de compositions selon l'invention sont donnés à titre d'illustration et sans caractère limitatif. Les composés sont indiqués en nom chimique ou en nom INCI. Les teneurs des ingrédients sont exprimées en pourcentage pondéral. The following examples of compositions according to the invention are given by way of illustration and without limitation. The compounds are indicated in chemical name or INCI name. The contents of the ingredients are expressed in percentage by weight.
Exemple 1 : Evaluation de la stabilité de formulations Mode de préparation : Example 1: Evaluation of the stability of formulations Method of preparation :
On mélange le polymère (homopolymère de vinylpyrrolidone (PVP)) dans l'eau par simple mise en contact sous agitation magnétique à température ambiante. On prépare ensuite la solution de composé 1 dans le dipropyleneglycol, en chauffant à environ 50°C pendant environ 10 minutes sous agitation magnétique. On verse dessus la solution de polymère dans l'eau à température ambiante.  The polymer (homopolymer of vinylpyrrolidone (PVP)) is mixed in the water simply by contacting with magnetic stirring at room temperature. The solution of compound 1 in dipropylene glycol is then prepared by heating at about 50 ° C for about 10 minutes with magnetic stirring. The polymer solution is poured into the water at room temperature.
Protocole d'évaluation: Evaluation Protocol:
On évalue la stabilité de la préparation obtenue conservée à 4°C et à température ambiante au bout de 24H par un contrôle macroscopique à l'œil (observation ou non d'un trouble ou d'un dépôt) et par observation au microscope sous lumière polarisée (présence ou non de cristaux) puis après 2 mois de stockage.  The stability of the obtained preparation stored at 4 ° C. and at room temperature after 24 hours is evaluated by a macroscopic examination with the eye (observation or not of a cloudiness or a deposit) and by observation under a microscope under a light. polarized (presence or absence of crystals) and after 2 months of storage.
On a obtenu les résultats suivants avec différentes associations évaluées: The following results were obtained with different associations evaluated:
Figure imgf000017_0001
Figure imgf000017_0001
On a obtenu les mêmes résultats en remplaçant le PVPK30L (masse moléculaire moyenne en poids allant de 40000 Daltons à 80000 Daltons) par le PVP K90 (masse moléculaire moyenne en poids allant d'allant de 900000 Daltons à 1500000 Daltons). The same results were obtained by replacing PVPK30L (weight average molecular weight ranging from 40000 Daltons to 80000 Daltons) with PVP K90 (weight average molecular weight ranging from 900000 Daltons to 1500000 Daltons).
On a ainsi constaté que de manière inattendue que les compositions 1A, 1 B, et 1 C conformes à l'invention, sont stables à température ambiante et à 4°C, et ne présentent aucune recristallisation du composé 1 , ce dérivé de résorcinol est donc très bien solubilisé dans ces associations particulières. It has thus been found that, unexpectedly, the compositions 1A, 1B, and 1C in accordance with the invention are stable at room temperature and at 4 ° C., and show no recrystallization of compound 1, this resorcinol derivative is so very well solubilized in these particular associations.
Exemples 2 à 5 Examples 2 to 5
Composition en %MA 2 3 4 5 Composé 1 : 4- 1 1 1 1Composition in% MA 2 3 4 5 Compound 1: 4- 1 1 1 1
(Tétrahydro-pyran-4-yl)- benzène-1 ,3-diol (Tetrahydro-pyran-4-yl) benzene-1,3-diol
Dipropylène glycol 23 23 23 23 Dipropylene glycol 23 23 23 23
Phénoxyéthanol 0,8 0,8 0,8 0,8Phenoxyethanol 0.8 0.8 0.8 0.8
Alcool polyvinylique 7 Polyvinyl alcohol 7
(SELVOL 540 SM de  (SELVOL 540 SM from
SEKISUI SPECIALTY SEKISUI SPECIALTY
CHEMICALS) Chemicals)
Hydroxypropyl méthyl - 0,4 - - cellulose  Hydroxypropyl methyl - 0,4 - - cellulose
(METHOCEL E 4 M  (METHOCEL E 4 M
PREMIUM de DOW  PREMIUM from DOW
CHEMICAL)  Chemical)
Hydroxyéthylcellulose 0,4 (NATROSOL 250 HHR  Hydroxyethylcellulose 0.4 (NATROSOL 250 HHR
CS de ASHLAND)  CS of ASHLAND)
Homopolymère réticulé - - 1 ,95 - d'Acide  Crosslinked Homopolymer - - 1, 95 - Acid
acrylamidométhyl  acrylamidomethyl
propane sulfonique  propane sulfonic
neutralisé partiellement à  partially neutralized
l'ammoniaque  ammonia
(Hostacerin AMPS® de (Hostacerin AMPS ® from
Clariant)  Clariant)
Eau QSP 100% QSP 100% QSP 100% QSP 100% Water QSP 100% QSP 100% QSP 100% QSP 100%
Stabilité Pas de Pas de Pas de Pas de cristaux cristaux cristaux cristaux après 2 mois après 2 mois après 10 après 10 à 4°C et à à 4°C et à jours à 4°C jours à 4°C température température et à et à ambiante ambiante température température ambiante ambiante Stability No Step Paste Crystals Crystals Crystals crystals after 2 months after 2 months after 10 after 10 at 4 ° C and at 4 ° C and at days at 4 ° C days at 4 ° C temperature temperature and at and at ambient room temperature room temperature
Exemple 6 : Composition de soin selon l'invention On a préparé une composition de soin de la peau (émulsion huile-dans-eau) ayant la composition suivante : EXAMPLE 6 Care Composition According to the Invention A skin care composition (oil-in-water emulsion) having the following composition was prepared:
Nom INCI INCI name
METHYL GLUCETH-20 3 METHYL GLUCETH-20 3
TETRASODIUM EDTA 0,1  TETRASODIUM EDTA 0.1
GLYCERYL STEARATE 1 ,45  GLYCERYL STEARATE 1, 45
(and) PEG-100 STEARATE  (and) PEG-100 STEARATE
(ARLACEL® 165 FL de chez  (ARLACEL® 165 FL from
UNIQEMA)  Uniqema)
STEARIC ACID 1 CETYL ALCOHOL 0,75 STEARIC ACID 1 CETYL ALCOHOL 0,75
DIISOPROPYL SE BAC AT E 4,5  DIISOPROPYL SE BAC AT E 4,5
TOCOPHEROL 0,10  TOCOPHEROL 0.10
DIMETHICONE 2,5  DIMETHICONE 2,5
GLYCERINE 7  GLYCERINE 7
CONSERVATEUR 0,5  CONSERVATIVE 0.5
DIPROPYLENE GLYCOL 10  DIPROPYLENE GLYCOL 10
EAU Qsp 100  WATER Qs 100
Composé 1 : 4-(Tétrahydro- 0,5  Compound 1: 4- (Tetrahydro-0.5
pyran-4-yl)-benzène-1 ,3-diol  pyran-4-yl) -benzene-1,3-diol
XANTHAN GUM 0,1  XANTHAN GUM 0,1
ACRYLATES/C 10-30 ALKYL 0,2  ACRYLATES / C 10-30 ALKYL 0.2
ACRYLATE ACRYLATE
CROSSPOLYMER CROSSPOLYMER
(PEMULEN TR2)  (PEMULEN TR2)
Polyvinylpyrrolidone de 3  Polyvinylpyrrolidone of 3
masse moléculaire moyenne  average molecular weight
en poids de 30000 Daltons  in weight of 30000 Daltons
(PVP K 30L® de la société  (PVP K 30L® of the company
ISP)  ISP)
ETHANOL 6  ETHANOL 6
Les composés hydrophobes sont chauffés indépendamment de ceux de la phase hydrophile à 70°C. On additionne la phase huile dans la phase eau sous agitation puis on ajoute les épaississants et les composés volatiles. The hydrophobic compounds are heated independently of those of the hydrophilic phase at 70 ° C. The oil phase is added to the water phase with stirring and then the thickeners and the volatile compounds are added.
La composition est stable et homogène après stockage pendant 1 mois à 45 °C. The composition is stable and homogeneous after storage for 1 month at 45 ° C.
Cette composition peut être appliquée régulièrement sur la peau du visage afin d'atténuer les signes de vieillissement cutané et d'éclaircir la peau. This composition can be applied regularly to the skin of the face to reduce the signs of skin aging and lighten the skin.

Claims

REVENDICATIONS
1 . Composition comprenant : 1. Composition comprising:
a) au moins un glycol ;  a) at least one glycol;
b) au moins un polymère non ionique ou anionique choisi parmi  b) at least one nonionic or anionic polymer selected from
- les homo- et copolymères de vinylpyrrolidone,  homopolymers and copolymers of vinylpyrrolidone,
- les alcools polyvinyliques,  polyvinyl alcohols,
- les celluloses,  - celluloses,
- les homo- et copolymères de monomères à groupement sulfonique, et leurs mélanges.  homopolymers and copolymers of monomers containing a sulfonic group, and mixtures thereof.
c) de l'eau ;  c) water;
d) au moins un composé 4-(hétérocycloalkyl)-benzène-1 ,3-diol de formule générale (I) suivante :  d) at least one 4- (heterocycloalkyl) -benzene-1,3-diol compound of the following general formula (I):
Figure imgf000020_0001
Figure imgf000020_0001
dans laquelle in which
R1 , R2, R3, R4, identiques ou différents, représentent  R1, R2, R3, R4, identical or different, represent
- un hydrogène,  a hydrogen,
- un radical alkyle en C1 -C4,  a C1-C4 alkyl radical,
- un hydroxyméthyle, un hydroxyethyle,  a hydroxymethyl, a hydroxyethyl,
- un alkoxy C1 -C4 carbonyle,  a C1-C4 alkoxycarbonyl,
- un alkoxy C1 -C4,  a C1-C4 alkoxy,
- un hydroxyle,  a hydroxyl,
ou or
R1 et R2 sont reliés entre eux et forment un cycle carboné à 5 ou 6 atomes de carbone avec l'atome de carbone auquel ils sont liés et R3 et R4, identiques ou différents, représentent : R1 and R2 are interconnected and form a carbon ring with 5 or 6 carbon atoms with the carbon atom to which they are bonded and R3 and R4, identical or different, represent:
- un hydrogène  - a hydrogen
- un radical alkyle en C1 -C4  a C1-C4 alkyl radical
ou or
R1 et R4 sont reliés entre eux et forment une chaîne -(CH2)2- ou -(CH2)3- et R2 et R3, identiques ou différents, représentent : R1 and R4 are connected together and form a chain - (CH2) 2 - or - (CH2) 3 - and R2 and R3, which are identical or different, represent:
- un hydrogène  - a hydrogen
- un radical alkyle en C1 -C4 X représente un atome d'oxygène, ou un atome de soufre. a C1-C4 alkyl radical X represents an oxygen atom, or a sulfur atom.
Y représente un hydrogène, un atome de chlore ou un atome de fluor, Y represents a hydrogen, a chlorine atom or a fluorine atom,
m peut prendre les valeurs 1 ou 2 et n peut prendre les valeurs 0 ou 1 et lorsque n=0, alors m=1 ou 2, et lorsque n=1 , alors m=1. m can take the values 1 or 2 and n can take the values 0 or 1 and when n = 0, then m = 1 or 2, and when n = 1, then m = 1.
ainsi que les sels des composés de formule générale (I), et leurs formes isomères et énantiomères, les hydrates et les solvates. as well as the salts of the compounds of general formula (I), and their isomeric and enantiomeric forms, hydrates and solvates.
2 - Composition selon la revendication 1 caractérisée en ce que dans le composé d) de formule (I): 2 - Composition according to claim 1 characterized in that in the compound d) of formula (I):
- R1 représente un hydrogène, un radical alkyle en C1 -C4 ou un radical hydroxyméthyle, R1 represents a hydrogen, a C1-C4 alkyl radical or a hydroxymethyl radical,
- R2 représente un hydrogène, R2 represents a hydrogen,
- R3 représente un hydrogène,  R3 represents a hydrogen,
- R4 représente un hydrogène,  R4 represents a hydrogen,
- X représente un atome d'oxygène X represents an oxygen atom
- Y représente un hydrogène ou un atome de fluor  Y represents a hydrogen or a fluorine atom
- m = 1 et n = 1 ,  - m = 1 and n = 1,
ainsi que les sels de ces composés et leurs formes isomères et énantiomères, les hydrates et les solvates. as well as the salts of these compounds and their isomeric and enantiomeric forms, hydrates and solvates.
3 - Composition selon l'une des revendications 1 à 2 caractérisée en ce que le ou les composés d) de formule (I) sont choisis dans le groupe constitué par : 3 - Composition according to one of claims 1 to 2 characterized in that the compound or compounds d) of formula (I) are chosen from the group consisting of:
1 : 4-(tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  1: 4- (tetrahydro-pyran-4-yl) benzene-1,3-diol
2 : 4-(tétrahydro-thiopyran-4-yl)-benzène-1 ,3-diol  2: 4- (tetrahydro-thiopyran-4-yl) -benzene-1,3-diol
3: 4-( cis-2,6-Diméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol 3: 4- (cis-2,6-Dimethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
4 : trans-4-(2-méthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  4: trans-4- (2-methyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
5 : cis-4-(2-méthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  5: cis-4- (2-methyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
6 : trans-4-(2-Ethyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  6: trans-4- (2-Ethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
7 : cis-4-(2-Ethyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  7: cis-4- (2-Ethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
8 : trans-4-(2-Hydroxyméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol 8: trans-4- (2-Hydroxymethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
9 : 4-(2,2,6,6-tétraméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  9: 4- (2,2,6,6-tetramethyltetrahydro-pyran-4-yl) benzene-1,3-diol
10 : 4-(tétrahydro-furan-3-yl)-benzène-1 ,3-diol  10: 4- (tetrahydro-furan-3-yl) -benzene-1,3-diol
1 1 : 4-(tétrahydro-thiophen-3-yl)-benzène-1 ,3-diol  1: 4- (tetrahydro-thiophen-3-yl) -benzene-1,3-diol
12 : 4-(6-Oxa-spiro[4.5]dec-9-yl)-benzène-1 ,3-diol  12: 4- (6-Oxa-spiro [4.5] dec-9-yl) -benzene-1,3-diol
13 : 4-Chloro-6-(tétrahydro-pyran-4-yl)-benzène-1 ,3-diol 13: 4-Chloro-6- (tetrahydro-pyran-4-yl) -benzene-1,3-diol
14 : 4-Fluoro-6-(tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  14: 4-Fluoro-6- (tetrahydro-pyran-4-yl) -benzene-1,3-diol
15 : 4-(2,2-Diethyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  15: 4- (2,2-Diethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
16 : 4-(tétrahydro-pyran-3-yl)-benzène-1 ,3-diol  16: 4- (tetrahydro-pyran-3-yl) -benzene-1,3-diol
17 : trans-4-(5-Hydroxyméthyl-tétrahydro-furan-3-yl)-benzène-1 ,3-diol 18 : cis-4-(5-Hydroxyméthyl-tétrahydro-furan-3-yl)-benzène-1 ,3-diol 17: trans-4- (5-Hydroxymethyl-tetrahydro-furan-3-yl) -benzene-1,3-diol 18: cis-4- (5-Hydroxymethyl-tetrahydro-furan-3-yl) -benzene-1,3-diol
19 : trans-4-Fluoro-6-(5-hydroxyméthyl-tétrahydro-furan-3-yl)-benzène-1 ,3-diol  19: trans-4-Fluoro-6- (5-hydroxymethyl-tetrahydro-furan-3-yl) -benzene-1,3-diol
20 : cis-4-Fluoro-6-(5-hydroxyméthyl-tétrahydro-furan-3-yl)-benzène-1 ,3-diol  20: cis-4-Fluoro-6- (5-hydroxymethyl-tetrahydro-furan-3-yl) -benzene-1,3-diol
21 : trans-4-Fluoro-6-(2-hydroxyméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  21: trans-4-Fluoro-6- (2-hydroxymethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
22 : cis-4-Fluoro-6-(2-hydroxyméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol 22: cis-4-Fluoro-6- (2-hydroxymethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
23 : cis-4-(8-Oxa-bicyclo[3.2.1 ]oct-3-yl)-benzène-1 ,3-diol  23: cis-4- (8-Oxa-bicyclo [3.2.1] oct-3-yl) -benzene-1,3-diol
24 : trans-4-(8-Oxa-bicyclo[3.2.1 ]oct-3-yl)-benzène-1 ,3-diol  24: trans-4- (8-Oxa-bicyclo [3.2.1] oct-3-yl) -benzene-1,3-diol
25 : 4-Fluoro-6-(tétrahydro-thiopyran-4-yl)-benzène-1 ,3-diol 4 - Composition selon l'une des revendications 1 à 3 caractérisée en ce que le composé de formule (I) est le 4-(tétrahydro-pyran-4-yl)-benzène-1 ,3-diol.  25: 4-Fluoro-6- (tetrahydro-thiopyran-4-yl) -benzene-1,3-diol 4 - Composition according to one of Claims 1 to 3, characterized in that the compound of formula (I) is 4- (Tetrahydro-pyran-4-yl) -benzene-1,3-diol.
5. Composition selon l'une des revendications 1 à 4, caractérisée en ce que le ou les composés de formule (I) sont présents en une teneur allant de 0,001 % à 10 % en poids, par rapport au poids total de la composition, plus particulièrement en une teneur allant de 0,05 % à 5 % en poids, et de préférence allant de 0,1 % à 2 % en poids, et préférentiellement allant de 0,2 % à 1 ,5 % en poids. 5. Composition according to one of claims 1 to 4, characterized in that the compound (s) of formula (I) are present in a content ranging from 0.001% to 10% by weight, relative to the total weight of the composition, more particularly in a content ranging from 0.05% to 5% by weight, and preferably ranging from 0.1% to 2% by weight, and preferably ranging from 0.2% to 1.5% by weight.
6. Composition selon l'une quelconque des revendications précédentes, caractérisée en ce que le(s)dit glycol a) est choisi(s) parmi le propylène glycol, le butylène glycol, le pentylène glycol, l'hexylène glycol, le dipropylène glycol, le diéthylène glycol, le 1 ,3- propanediol, le 1 ,5-pentanediol, les polyéthylènes glycol, et un de leurs mélanges. 6. Composition according to any one of the preceding claims, characterized in that (s) said glycol a) is chosen from propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol diethylene glycol, 1,3-propanediol, 1,5-pentanediol, polyethylene glycol, and a mixture thereof.
7. Composition selon l'une quelconque des revendications précédentes, caractérisée en ce que le(s)dit glycol(s) est choisi(s) parmi le dipropylène glycol, le propylène glycol, le butylène glycol, et leurs mélanges. 7. Composition according to any one of the preceding claims, characterized in that said glycol (s) is chosen from dipropylene glycol, propylene glycol, butylene glycol, and mixtures thereof.
8. Composition selon l'une quelconque des revendications précédentes, caractérisée par le fait que le(s)dit glycol(s) est présent(s) en une teneur allant de 0,50 % à 50 % en poids, par rapport au poids total de la composition, de préférence allant de 3 % à 30 % en poids, et préférentiellement allant de 5 % à 20 % en poids, par rapport au poids total de la composition. 8. Composition according to any one of the preceding claims, characterized in that the said glycol (s) is present (s) in a content ranging from 0.50% to 50% by weight, relative to the weight total of the composition, preferably ranging from 3% to 30% by weight, and preferably ranging from 5% to 20% by weight, relative to the total weight of the composition.
9. Composition selon l'une quelconque des revendications précédentes, caractérisée par le fait que le ou les polymères b) sont choisis parmi les hydroxyalkyl (C1 -C4) celluloses et les hydroxyalkyl (C1 -C4) alkyl (C1 -C4) celluloses. 9. Composition according to any one of the preceding claims, characterized in that the polymer (s) b) are chosen from hydroxyalkyl (C1 -C4) celluloses and hydroxyalkyl (C1 -C4) alkyl (C1 -C4) celluloses.
10. Composition selon l'une quelconque des revendications précédentes, caractérisée en ce que le ou les polymères b) sont choisis parmi les homo- et copolymères de vinylpyrrolidone tels que les homopolymères de polyvinylpyrrolidones (PVP), les polyvinylpyrrolidones complexées à l'iode, les copolymères polyvinylpyrrolidone/acétate de vinyle (PVPA A), polyvinylpyrrolidone/butène ; polyvinylpyrrolidone/décène, polyvinylpyrrolidone/hexadécène, polyvinylpyrrolidone/acide(méth)acrylique/méthacrylate d'alkyl en C8-C20, polyvinylpyrrolidone/acétate de vinyle/ acide itaconique, polyvinylpyrrolidone/acétate de vinyle/ propionate de vinyle. 10. Composition according to any one of the preceding claims, characterized in that the polymer (s) b) are chosen from homo- and copolymers of vinylpyrrolidone such as homopolymers of polyvinylpyrrolidones (PVP), polyvinylpyrrolidones complexed with iodine, polyvinylpyrrolidone / vinyl acetate copolymers (PVPA A), polyvinylpyrrolidone / butene; polyvinylpyrrolidone / decene, polyvinylpyrrolidone / hexadecene, polyvinylpyrrolidone / (meth) acrylic acid / C8-C20 alkyl methacrylate, polyvinylpyrrolidone / vinyl acetate / itaconic acid, polyvinylpyrrolidone / vinyl acetate / vinyl propionate.
1 1 . Composition selon l'une quelconque des revendications précédentes, caractérisée par le fait que ledit polymère b) est un polymère à groupement sulfonique choisi parmi un polymère d'acide 2-acrylamido 2-méthylpropane sulfonique et ses sels. 1 1. Composition according to any one of the preceding claims, characterized in that the said polymer b) is a polymer with a sulphonic group chosen from a polymer of 2-acrylamido-2-methylpropanesulphonic acid and its salts.
12. Composition selon l'une quelconque des revendications précédentes, caractérisée par le fait que ledit polymère b) est un polymère de monomère à groupement sulfonique choisi parmi un homopolymère réticulé d'acide 2-acrylamido 2-méthylpropane sulfonique et ses sels. 12. Composition according to any one of the preceding claims, characterized in that said polymer b) is a monomer polymer containing sulfonic group selected from a crosslinked homopolymer of 2-acrylamido-2-methylpropanesulfonic acid and its salts.
13. Composition selon l'une quelconque des revendications précédentes, caractérisée en ce que le (ou les) polymères b) sont présents à une teneur allant 0,01 % à 15 % en poids, de préférence allant de 0,1 % à 10 % en poids. 13. Composition according to any one of the preceding claims, characterized in that the (or) polymers b) are present in a content ranging from 0.01% to 15% by weight, preferably from 0.1% to 10% by weight. % in weight.
14. Composition selon l'une quelconque des revendications précédentes, caractérisée en ce qu'elle se présente sous la forme d'une émulsion eau-dans-huile ou huile-dans-eau, de préférence une émulsion huile-dans-eau. 14. Composition according to any one of the preceding claims, characterized in that it is in the form of a water-in-oil or oil-in-water emulsion, preferably an oil-in-water emulsion.
15. Composition selon l'une quelconque des revendications précédentes, caractérisée en ce qu'elle est une composition cosmétique. 15. Composition according to any one of the preceding claims, characterized in that it is a cosmetic composition.
16. Procédé de traitement cosmétique des matières kératiniques comprenant l'application sur les matières kératiniques, telles que la peau, d'une composition selon l'une quelconque des revendications précédentes. 16. A process for the cosmetic treatment of keratin materials comprising the application to keratin materials, such as the skin, of a composition according to any one of the preceding claims.
17. Procédé cosmétique de dépigmentation, d'éclaircissement et/ou de blanchiment des matières kératiniques, notamment la peau humaine, les poils ou les cheveux comprenant l'application sur lesdites matières kératiniques d'une composition telle que définie selon l'une quelconque des revendications 1 à 15. 17. A cosmetic process for depigmenting, lightening and / or bleaching keratinous substances, in particular human skin, hair or hair, comprising applying to said keratin materials a composition as defined according to any one of the following: Claims 1 to 15.
PCT/EP2015/080645 2014-12-22 2015-12-18 Aqueous composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound, a polymer and a glycol WO2016102398A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1463139A FR3030249B1 (en) 2014-12-22 2014-12-22 AQUEOUS COMPOSITION COMPRISING A 4- (HETEROCYCLOALKYL) -BENZENE-1,3-DIOL COMPOUND, A POLYMER AND A GLYCOL
FR1463139 2014-12-22

Publications (1)

Publication Number Publication Date
WO2016102398A1 true WO2016102398A1 (en) 2016-06-30

Family

ID=52692858

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2015/080645 WO2016102398A1 (en) 2014-12-22 2015-12-18 Aqueous composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound, a polymer and a glycol

Country Status (2)

Country Link
FR (1) FR3030249B1 (en)
WO (1) WO2016102398A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2939136A1 (en) * 2008-12-02 2010-06-04 Galderma Res & Dev NOVEL 4- (HETEROCYCLOALKYL) -BENZENE-1,3-DIOL COMPOUNDS AS TYROSINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2939136A1 (en) * 2008-12-02 2010-06-04 Galderma Res & Dev NOVEL 4- (HETEROCYCLOALKYL) -BENZENE-1,3-DIOL COMPOUNDS AS TYROSINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS

Also Published As

Publication number Publication date
FR3030249B1 (en) 2018-11-02
FR3030249A1 (en) 2016-06-24

Similar Documents

Publication Publication Date Title
EP2694022B1 (en) Cosmetic composition including a cucurbic acid compound and a mixture of sulfonic and acrylic polymers
RU2589827C2 (en) Cosmetic composition containing 4-(3-ethoxy-4-hydroxyphenyl)-2-butanone
FR2973228A1 (en) COSMETIC COMPOSITION COMPRISING 4- (3-ETHOXY-4-HYDROXYPHENYL) BUTAN-2-ONE
EP0966948A1 (en) Cosmetic composition containing an anionic polymer and an acrylic terpolymer and use of said composition for treating keratinic materials
FR2973691A1 (en) COSMETIC COMPOSITION COMPRISING A CUCURBIC ACID COMPOUND AND A SEMICRYSTALLINE ACRYLIC POLYMER
FR2968950A1 (en) COSMETIC COMPOSITION COMPRISING A CUCURBIC ACID COMPOUND AND AN ACRYLIC COPOLYMER
EP2100586B1 (en) Cosmetic composition comprising an ascorbic acid or salicylic acid compound
FR2963250A1 (en) WATER-LIKE EMULSION WITHOUT SURFACTANT, PREPARATION METHOD AND USES THEREOF
FR3030231A1 (en) USE OF A FATTY ACID ESTER FOR MATIFYING THE SKIN AND COMPOSITION COMPRISING SAID ESTER
CA2568262A1 (en) Hydroalcoholic depigmentation gel comprising mequinol and adapalene
FR3117799A1 (en) Composition comprising aqueous gelling agents, surfactant, oils, fillers and ascorbic acid
FR3089122A1 (en) Composition comprising hectorite and pectin
FR2988292A1 (en) Cosmetic composition in oil-in-water emulsion form, used to treat keratinous materials e.g. skin of human beings, comprises cyclopentanol compound, sugar ether, an oil phase comprising semicrystalline acrylic polymer and aqueous phase
FR2973693A1 (en) Oil-in-water emulsion composition, useful e.g. for caring keratinous materials (lips), comprises cyclopentanol compound, alkylpolyglycoside surfactant, homopolymer of monomer having sulfonic group and homopolymer of acrylic acid, in medium
FR2928541A1 (en) Composition, useful for care/make-up of keratin materials e.g. lips, comprises: fatty acid ester and polyethylene glycol; additional surfactant; polycondensate of ethylene oxide and propylene oxide; and active ingredient e.g. ascorbic acid
FR3008611A1 (en) COSMETIC COMPOSITION COMPRISING A CUCURBIC ACID COMPOUND AND ANIONIC SURFACTANT DERIVED FROM AMINO ACID
EP3038597A2 (en) Cosmetic composition comprising a sulphonic polymer, a hydrophobic polysaccharide and a silicone surfactant
FR2810543A1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A DEXTRIN ESTER AND A HYDROPHILIC GELLING AGENT
WO2014170591A1 (en) Cosmetic composition comprising a cucurbic acid compound and a (poly)oxyalkylenated polar oil
WO2016102402A1 (en) Aqueous composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound, a c2-c4 monoalcohol, and a glycol
WO2016102398A1 (en) Aqueous composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound, a polymer and a glycol
FR2928540A1 (en) Composition, useful for care/make-up of keratin materials e.g. lips, comprises: fatty acid ester and polyethylene glycol; additional surfactant; polycondensate of ethylene oxide and propylene oxide; and active ingredient e.g. ascorbic acid
FR3029780A1 (en) COMPOSITION COMPRISING HESPERETIN
WO2016102399A1 (en) Aqueous composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound and a hydrotrope
FR3030251A1 (en) COMPOSITION COMPRISING 4- (HETEROCYCLOALKYL) -BENZENE-1,3-DIOL COMPOUND AND A PARTICULATE SOLVENT

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15816767

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15816767

Country of ref document: EP

Kind code of ref document: A1